MODUL 5 FIX
-
Upload
haura-nadya-amalia -
Category
Documents
-
view
33 -
download
2
description
Transcript of MODUL 5 FIX
CHAPTER 1
INTRODUCTION
1.1 Background
Infectious disease are disorders caused by organisms — such as bacteria,
viruses, fungi or parasites. Many microorganisms colonize in and on our bodies.
They're normally harmless or even helpful, but under certain conditions may cause
disease. Some infectious disease can be passed from person to person. Some,
however, are transmitted via bites from insects or animals. Others are acquired by
ingesting contaminated food or water or other exposures in the environment. Signs
and symptomps of infectious diseases vary, but often include fever and chills. Mild
complaints may respond to home remedies, while some life-threatening infections
may require hospitalization and intravenous antibiotics.
Infection refers to the ability of microorganism to invade tissue and find
condition that are suitable for growth and replication. It should be noted that it is, in
general, not in the interests of the organism to destroy the host; rather it is preferable
to find an ecological niche that will allow tissue colonization with perhaps some
replication, but without the risks of invasion. It is the exception for microorganisms
to cause infection rather than the rule. Alterations in the site of colonization, the
bacterial density or level of host immune competence will alter the likelihood of
infection. Infection is also sometimes a function of the host’s response to
microorganisms. Infections may cause either clinical or subclinical illness i.e.
apparent versus inapparent illness. Many individuals develop an immune response to
a pathogen without manifesting any signs of illness.
Periodontal disease, is the most common disease in the world and the leading
cause of tooth loss in adults is a chronic infection that slowly attacks and destroys the
gums and bone that support the teeth. Symptoms associated with periodontal disease
are sore, inflamed gums that have a tendency to bleed. Estimations have shown that at
least 75 percent of the adult population in America has some form of periodontal
1
disease. Adults are not the only group susceptible to the disease; one-third of children
ages 6-11 and two-thirds of adolescents have some form of periodontal disease
Periodontal disease is caused by more than 200 species of bacteria. These
bacteria form masses of sticky film called plaque, which is able to adhere to the
surface of teeth and gums. The bacteria are then nourished by the consumption of
foods, especially sweets. The sugars are metabolized by the bacteria which causes the
secretion of acids, enzymes, and other soft tissue irritants and bone destroyers. When
left untreated, the bacteria begin to spread to areas that are hard to reach with normal
brushing and flossing; for instance, areas below the gum line, thus causing
periodontal disease (periodontal).
1.2 Problems
In this case, a man with 50 years old was being treated in hospital, reffered to
dental clinic for dental treatment especially molar treatment that had cavity and
continous pain and also bleeding.The patient had shortness breathing for the last 2
weeks with continous chest pain and chronic cough for more than 1 month. Patient
had fever for the last 2 weeks especially in the evening, sweat in the night, loss of
appetite and loss of weight.
1.3 Purpose
The purpose for making this paper :
• To know about basic concept of infection and spread of infection itself
• To know the importance of maintaining healthy teeth
• Understand the symptoms caused by infectious disease so as to choose the
appropriate treatment for patients.
1.4 Benefit
The benefit is we can figure out how the mechanism of occurrence infectious
disease so as to provide the best treatment to the patient and dentist himself/herself
2
CHAPTER 2
THEORITICAL REVIEW
2.1 CARIES
Caries is the process of deterioration of enamel, dentine and pulpa weefsel.
The lesion as a result of this damage occurs, a carious lesion is characterized by
demineralization of the inorganic component of tooth structure and disintegration of
the organic component. The development of a lesion is an intermittent process of
demineralization and remineralization, which is an important component of the
microbial cariogenic plaque.2
Tooth decay, or dental caries, is one of the two most prevalent forms of dental
disease, periodontal disease being the other. For major factors are necessary for caries
to occur: a susceptible tooth, presence of acid-producing bacteria, access to
fermentable carbohydrates (predominantly sugar) and time. Dental caries is the
dissolution of both enamel and dentin by the acid by-products of certain bacteria
living on the tooth surfaces.3
Dental caries starts slowly because the process must first works its way
through the highly mineralized enamel surface of the tooth. Once the process reaches
the less mineralized dentin, the speed of destruction increases. Left alone, the decay
may eventually close in on the pulp, causing pain, possible pulpal death, and abscess
formation.4
Dental caries is a proceed that may take place on any tooth surface in the oral
cavity where dental plaque is allowed to develop over a period of time. Plaque
formaton is a natural. Plaque is an example of a biofilm, which means it is not a
haphazard collection of bacteria but a community of microorganisms attached to a
surface. This community works together, having a collective physiology. The bacteria
in the biofilm are always metabolically active. Some of the bacteria are capable of
fermenting a suitable dietary carbohydrate substrate (such as the sugars sucrose and
glucose), to produce acid, causing the plaque pH to fall to below 5 within 1-3
minutes. Repeated falls in pH may in time result in demineralization of the tooth
3
surface. However, the acid produced is neutralized by saliva, so the pH increases and
mineral may be regained. This is called remineralization. The cumulative results of
the deand remineralization processes may be a net loss of mineral and a carious lesion
that can be seen. Alternatively, the changes may be so slight that a carious lesion
never becomes apparent.5
The metabolism of this plaque is influenced by several factors including diet,
oral hygiene, saliva composition and presence of fluoride. The dynamic nature of the
caries process is the balance between these factors. The caries process is not time-
called a halt - by preventive or restorative measures - will extend to the lesion there is
a 'deep' carious lesion or caries profunda.
At an early stage, reactions to the caries process observed in the pulp dentine
complex. Whether these reactions occur with the initial (enamel) lesion or only at the
dentinelaesie in the literature is still disputed.6
Caries can be subdivided according to the extent of the damage it has already
caused. Caries initialis or caries superficialis occurs if the caries is located within the
enamel. A caries affliction of the dentin is caries media or caries profunda, depending
on the depth of the dentin caries.
1. Caries initialis
Initial caries is still reversible. The loss of minerals in the enamel is displayed
as a whitish spot. It can be repaired through the redeposition of mineral substances.
The affected areas are treated with a fluoride gel or a fluoride solution. This serves to
4
Figure 2.1. Initial caries (white spot lesions)
promote the redeposition of mineral substances (remineralisation).1
2. Caries superficialis
Superficial (surface) caries is irreversible. A first cavity is created by the
mineral loss occurring under an intact tooth surface. Defects such as these represent
ideal hiding places for bacteria. Plaque is permanently present in these defects. The
acid formed by the bacteria cannot be neutralised by saliva and leads to a further loss
in minerals. The expansion of caries superficialis is as yet still limited to the enamel
and does not cause pain.7
Tooth destruction through caries
If the carious process reaches the dentin, we speak of caries media. The
bacteria can now advance more rapidly through the little dentin canals within the
dentin. Caries can thus also advance more rapidly. Dentin caries can expand
considerably, even under an almost intact dental enamel surface. In the case of
extensive caries media, the probe remains stuck in the softened dentin. The larger the
defect, the more frequently decay processes (bacterial decay of food residues) take
place.
3. Caries profunda
If the dentin caries reaches the proximity of the pulpa.. The carious defect
with softened dentin has encompassed large areas of the tooth. Without therapy, the
tooth will be destroyed by the caries and as a consequence of bacterial damage caused
to the pulpa a pulpitis (inflammation of the dental pulp) would develop.7
A carious lesion has several distinctive areas : zone of bacterial invasion and
destruction, demineralized zone, sclerotic or transparent / translucent zone and a
reactive zone. At the histological level in these zones a number of responses to the
caries process which can not be removed. Destruction takes place in an area of dental
tissue caused by the action of acid and pro-teolytische enzymes produced by
anaerobic micro-organisms are formed in the microbial biomass present. Axially of
5
this zone there is bacterial invasion. The demineralized zone is generally not infected,
but is subject to the microorganisms diffusing acid. Due to the active, defensive
reaction of the mug-pa-dentine complex forms the transparent zone (zone 3).
Demineralization has increased porosity results. Now to increase diffusion of acid
and enzymes to combat turn until the odontoblasten tubular sclerosis. Intratubular
formation of hydroxylapatite and witlockietkristallen (ß-tricalcium phosphate)
significantly reduces the patency of the tubules. The reactive zone (zone 4) is named
after the deposition of reactionary or reparatief tertiary dentin on the pulpal side of
the pulp-Dentine complex. This dentin is less mineralized and composed of
irregularly shaped tubules. These local deposition of dentin is often accompanied by a
reduction in the number odontoblasten. Demineralization takes place at a distance of
0.5 to 1 millimeter to the mug-pa, then the inflammatory reactions observed in sub
odontoblastenlaag (zone of Weil). These often chronic inflammation with the
presence of lymphocytes, macrophages and plasma cells are probably due to the
presence of bacterial products.7
2.2 DIABETES MELITUS
Diabetes mellitus (DM) is a chronic, non-communicable disease and also one
of the major global public health issues. It produces many complex changes in the
lives of those affected. Diabetes mellitus is defined as a clinical syndrome
characterized by hyperglycemia due to absolute or relative deficiency of insulin.
Diabetes mellitus is an etiologically and clinically heterogeneous group of metabolic
disorders that share the commonality of hyperglycemia. It is chronic disorder
characterized by :
• Hyperglycemia
• Major abnormalities in carbohydrate, fat and protein metabolism.
• Marked propensity to develop relatively specific forms of vascular, renal, ocular,
neurologic and periodontal complications. It is a common disease with concomitant
oral manifestations that impact on dental care. Virtually every practicing dentist
encounters patients with known or undiagnosed diabetes. (Azodo, 2009)
6
There are four etiologic types of diabetes, although the most frequent are type
1 (90%) and 2 (5- 10%). Prevalence of diabetes in adults worldwide was estimated to
be 4% in 1995, and is predicted to rise to 5’4% by the year 2025. The countries with
the largest number of people with diabetes are India, China and the U.S. In
developing countries, the majority are in the age range of 45–64 years. In the
developed countries, the majority of people with diabetes are aged 65 years. There are
more women than men with diabetes. Poorly controlled diabetes could lead to
complications that may even be life- threatening. Long- term complications include:
retinopathy, nephropathy, autonomic neuropathy, peripheral neuropathy and
cardiovascular disease. The dentist plays a major role with other members of the
health team in helping a patient maintain glycemic control by achieving optimal oral
health; and by referring undiagnosed patients with complications suggestive of
diabetes to physicians for further evaluation. (Alamo et al, 2011)
Tabel 2.1 Criteria for the diagnosis of diabetes (American Diabetes Association,
2010)
2.2.1 Classification of diabetes mellitus
7
The criteria for diagnosis of diabetes include symptoms of hyperglycaemia
(polyuria, polydipsia, unexplained weight loss, visual blurring, genital thrush,
lethargy) associated with a raised random venous plasma glucose (≥11.1mmol/l)
level, or a raised fasting plasma glucose level (≥7.0mmol/l) in the presence or
absence of symptoms, with the test being performed on two separate occasions.
(Wilson et al, 2010)
There are three main categories of diabetes :
1. Type 1 (insulin-dependent diabetes mellitus), which results from an absolute
insulin deficiency.
2. Type 2 (non-insulin-dependent diabetes mellitus), which is the result of insulin
resistance and an insulin secretory defect.
3. Gestational diabetes presenting for the first time during pregnancy, which occurs in
2-5% of all pregnancies. Impaired glucose tolerance (IGT) and impaired fasting
glycaemia (IFG) are intermediate conditions in the transition between normality and
diabetes. Patients with these conditions are now referred to as having ‘pre diabetes’
and are at high risk of progressing to type 2 diabetes mellitus, although this is not
inevitable. IGT and IFG are associated with metabolic syndrome, which includes
obesity (especially abdominal or visceral obesity), dyslipidaemia of the high
triglyceride and/or low high-density lipoprotein (HDL) type, and hypertension.
(Wilson et al, 2010)
2.2.2 Factors that contribute in DM
Diabetes involves chronic levels of abnormally high glucose
(hyperglycemia). Many patients, especially those with type 2 diabetes, also have
elevated blood pressure (hypertension), chronic high levels of insulin
(hyperinsulinemia) and unhealthy levels of cholesterol and other blood fats
(hyperlipidemia). All of these factors contribute to the long-term complications of
diabetes, which include:
8
Vascular disease (diabetic angiopathy), atherosclerosis, heart conditions and
stroke: These cardiovascular disorders are the leading cause of death in people with
diabetes.
Kidney disease (diabetic nephropathy): Diabetes is the chief cause of end-
stage renal disease, which requires treatment with dialysis or a kidney transplant.
Eye diseases: These include diabetic retinopathy, glaucoma and cataracts.
Diabetes is a leading cause of visual impairment and blindness.
Nerve damage (diabetic neuropathy): This includes peripheral neuropathy,
which often causes pain or numbness in the limbs, and autonomic neuropathy, which
can impede digestion (gastroparesis) and contribute to sexual dysfunction and
incontinence. Neuropathy may also impair hearing and other senses.
Impaired thinking: Many studies have linked diabetes to increased risk of
memory loss, dementia, Alzheimer’s disease and other cognitive deficits. Recently
some researchers have suggested that Alzheimer’s disease might be “type 3 diabetes,”
involving insulin resistance in the brain.
Infections and wounds: Foot conditions and skin disorders, such as ulcers,
make diabetes the leading cause of nontraumatic foot and leg amputations. People
with diabetes are also prone to infections including periodontal disease, thrush,
urinary tract infections and yeast infections.
Cancer: Diabetes increases the risk of malignant tumors in the colon,
pancreas, liver and several other organs.
Musculoskeletal disorders: Conditions ranging from gout to osteoporosis to
restless legs syndrome to myofascial pain syndrome are more common in diabetic
patients than nondiabetics.
Pregnancy complications: Diabetes increases the risk of preeclampsia,
miscarriage, stillbirth and birth defects.
Emotional difficulties: Many but not all of the studies exploring connections
between diabetes and mental illness have found increased rates of depression, anxiety
and other psychological disorders in diabetic patients. In addition to chronic
hyperglycemia, diabetic patients can experience acute episodes of hyperglycemia as
9
well as hypoglycemia (low glucose). Severe cases can cause seizures, brain damage
and a potentially fatal diabetic coma. Acute glucose emergencies include:
Insulin shock: This advanced stage of hypoglycemia is typically due to
excessive amounts of insulin medication or certain antidiabetic agents.
Diabetic ketoacidosis: A lack of insulin can force the body to burn fats instead
of glucose for energy. The result is a toxic byproduct called ketones, along with
severe hyperglycemia.
Hyperosmolar hyperglycemic nonketotic state: This involves severe
hyperglycemia and dehydration.
2.2.3 Risk factors and causes of diabetes
The causes of diabetes are complex and only partly understood. This disease
is generally considered multifactorial, involving several predisposing conditions and
risk factors. In many cases genetics, habits and environment may all contribute to a
person’s diabetes.
Genetics and family history: Certain genes are known to cause maturity-onset
diabetes of the young (MODY) and Wolfram syndrome. Genes also contribute to
other forms of diabetes, including types 1 and 2.
Family medical history is also influential to varying degrees: For example, a
person whose parents both have type 1 diabetes has a 10 to 25% chance of developing
that disease, according to the American Diabetes Association, and someone whose
parents both have type 2 diabetes has a 50% chance of developing that disease.
Weight and body type: Overweight and obesity are leading factors in type 2
diabetes and gestational diabetes. Excess fat, especially around the abdomen (central
obesity), promotes insulin resistance and metabolic syndrome.
Sex : The prevalence of diabetes in American men and women was similar
until 1999, when a growing disparity began, according to an analysis of statistics
published by the U.S. Centers for Disease Control and Prevention (CDC). Little or no
research has been conducted to explain this trend. One factor may be the documented
10
increase in recent years of low testosterone levels (male hypogonadism), which
scientists have linked to insulin resistance.
Level of physical activity: Lack of regular exercise is blamed for much of the
twin global epidemics of obesity and diabetes.
Diet: The effect of diet in the development of diabetes is controversial. Some
studies have linked heavy consumption of soft drinks and other simple carbohydrates
to risk of metabolic diabetes, and foods low in the glycemic index, such as whole
grains, to reduced risk. Yet the ADA states that eating foods containing sugar does
not cause the disease. The culprit, rather, is the weight gain due to sedentary habits
and excess intake of calories, according to the ADA.
2.2.4 Treatment Of Diabetes Mellitus
Medical nutrition therapy (also known as dietary therapy) and lifestyle
modification form the centerpiece of the management of DM, irrespective of
modality of therapy chosen. The goals of therapy are to prevent complications of DM.
Tight blood glucose control prevents microvascular complications in both type 1 and
type 2 DM.11,34 Although glycemic control may not be as effective in reducing
macrovascular complications, aggressive therapies aimed at blood pressure levels,
lipid levels and smoking cessation are effective in preventing macrovascular
complications.
Insulin therapy
Insulin therapy is the mainstay for patients with type 1 DM, and, in most
patients, frequent multiple dosing (basal and bolus) plans are common. Continuous
insulin delivery via pumps also is a fairly common practice. All of these methods
typically involve subcutaneous injection, and a variety of insulin preparations can be
used that allow the physician and patient to select the best method on the basis of cost
and flexibility. Insulin therapy should mimic the physiological release of insulin,
which is characterized by a continuous basal secretion, to prevent fasting
hyperglycemia, as well as prandial insulin release to prevent postprandial
11
hyperglycemia. During fasting, long-acting basal insulin, which has a flat profile
without a peak, is used, and at mealtime, a bolus injection of fast-acting insulin is
administered to produce a peak coinciding with absorption of ingested carbohydrates.
In the past, insulin was derived from porcine and bovine sources. These sources have
been replaced by recombinant human insulin. Many types of insulin have been
developed to produce varying levels of onset of action, ranging from rapid-acting (for
example, analog insulins such as aspart, lispro and glulisine) to intermediateacting
(for example, neutral protamine Hagedorn, commonly referred to as NPH) to long-
acting (for example, glargine and detemir). Insulin pump therapy, also known as
continuous subcutaneous insulin infusion, is portable and provides flexibility and the
convenience of fewer injections, especially for patients with type 1 DM. The insulin
pump consists of an external pump and a needle inserted into the skin that are
connected by tubing. The pump has a reservoir, which is filled with rapid- or short-
acting insulin for continuous infusion. The pump can be programmed to deliver
different basal and bolus rates and allows delivery of sophisticated regimens of
insulin that can be customized to each patient’s lifestyle. The basis for any successful
insulin therapy is the ability of patients to monitor their own blood glucose levels by
using glucometers, education that allows patients to adjust their insulin doses, diet
and exercise to produce normoglycemia and prevent hypoglycemia. Insulin therapy is
associated with the risk of experiencing significant weight gain and developing
hypoglycemia.
Pramlintide
Since the secretion of amylin from islets in patients with type 1 DM also is
defective, amylin injections may help with glucose control. Amylin decreases
postprandial glucagon release and delays gastric emptying (similar to
actions of incretins), which may help prevent large excursions in glucose after meals.
The commercial preparation of amylin is pramlintide, which is approved by the U.S.
Food and Drug Administration for treatment of patients with both type 1 and type 2
12
DM. However, it has to be injected before each meal. For glucose control in patients
with type 1 DM, there are no orally active agents.
OHAs
These are the first-line agents used to treat patients with type 2 DM, and they
either increase pancreatic insulin secretion or improve insulin action (the term
“sensitizer” is used to describe them). Although debate continues about the merits of
one kind over another, each class of OHA generally is as effective as the other. At
first approximation, most OHAs lead to an average 1.0 to 1.2 percent decrease in
glycosylated hemoglobin (HbA1c). Insulin secretagogues are those that stimulate
insulin secretion from pancreatic beta cells. They are of value only in patients in
whom there is some residual pancreatic function. Their advantage is that they mimic
physiological insulin secretion. This class of agents includes sulfonylureas and
meglitinides, both of which work through sulfonylurea receptors on beta cells to
release insulin. Insulin sensitizers improve the action of insulin in target tissues
(hepatic, skeletal muscle and adipose tissues) in people with insulin resistance. This
class of agents includes biguanides (for example, metformin), which principally
reduces hepatic gluconeogenesis and improves muscles’ uptake of glucose, and
thiazolidinediones (for example, pioglitazone and rosiglitazone) that act primarily on
adipose and skeletal muscle to improve insulin action. α-Glucosidase inhibitors
(acarbose and miglitol) decrease glucose absorption in the gut.
Incretins
The newest group of oral agents used to treat patients with type 2 DM target
the incretin pathway. This group includes dipeptidyl peptidase IV inhibitors. These
agents prevent the rapid breakdown of two intestinally secreted hormones (glucagon-
like peptide-1 and gastricinhibitory peptide) that are released in response to meals.
These hormones increase insulin secretion, decrease glucagon secretion and delay
gastric emptying. 37-39 The incretin pathway is attenuated in patients with type 2
DM,40 and oral agents that specifically target the enzyme dipeptidyl peptidase IV
13
increase their half-lives in the bloodstream. Naturally occurring incretins in humans
have a short half-life and are not useful therapeutically. Exenatide is a synthetic
analog of Gila monster incretin (exendin-4), and it targets the glucagon-like peptide-1
receptor. It is an injectable drug, however, and leads to weight loss, unlike insulin,
which causes weight gain.41-44 Of all the approved agents used to treat DM, only
two (metformin and exenatide) consistently reduce weight, as well as improve
glycemic con trol. All other agents tend to lead to weight gain. These OHAs can be
used alone or in combination with one another and with insulin. Regimens should
complement each other and not produce the same effects; for example, combining a
sulfonylurea with a meglitinide may not be effective because both act on the
sulfonylurea receptors to release insulin. On the other hand, either of these can be
combined with any of the insulin sensitizers or the incretin therapies. Use of
combination therapies is commonplace for the control of DM.
Transplantation
Transplantation of the whole pancreas or isolated islet cells is one of the
treatment options for patients with type 1 DM. Islet cell transplantation is
experimental, whereas whole pancreas transplantation usually is performed in
conjunction with renal transplantation. If successful, both forms of transplantation
eliminate or reduce the need for intensive insulin therapy, which has been associated
with severe hypoglycemia, to attain nearly normal glycemic control. Whole pancreas
transplantation can be performed alone, in combination with kidney transplantation or
after kidney transplantation, and its success can be limited by organ availability, graft
failure and morbidity associated with immunosuppressive therapy and surgical
complications.46 Improvements in surgical techniques and immunosuppressive
therapy regimens have helped reduce morbidity and mortality, making this a viable
therapeutic alternative for the treatment of DM. The greatest promise of islet cell
transplantation is the possibility of immunosuppression-free transplantation,
obviating the high rates of adverse effects resulting from the use of
immunosuppressive agents. (Kidambi, 2008)
14
2.3 SMOKING
Smokers have greater susceptibility to periodontitis but paradoxically less
gingivitis. The reasons for this are not understood but smoking is known to interfere
with inflammatory and immune reactions probably by activating endothelial and
inflammatory cells inappropriately in the lungs and circulation, and by inducing them
to secrete cytokines and other compounds. Also, nicotine is a vasoconstrictor, though
its effects on the gingiva have proved difficult to measure. Overall, smokers have
greater loss of attachment, early tooth loss and respond less well to treatment.
(Slootweg PJ. 2007).
Smoking is known a risk factor for many diseases, and increasing evidence
suggests that smoking adversely affects periodontal health. The concept that smoking
tobacco may be detrimental to periodontal health is not new. In fact, Pindborg
observed an association between acute necrotizing ulcerative gingivitis and smoking
nearly 60 years ago. Since then, various investigators have attempted to identify the
role of tobacco smoking in the etiology of periodontal diseases. Earlier investigators
had attributed the increased prevalence and severity of periodontal disease seen in
smokers to the greater presence of plaque and calculus than compared to nonsmokers.
However, with the better understanding of the host response, evidence suggests that
the effect of smoking on periodontal status is independent from the plaque index and
oral hygiene of individual. So, this clearly suggests that smoking has a direct
influence on periodontal tissues. (Cawson, 2002)
Smokers have been associated with deeper pockets and greater attachment
loss, more pronounced radiographic evidence of furcation involvement, and increased
alveolar bone loss. There is an established biologic rationale for the negative effect of
smoking on periodontal tissues. It has an immunosuppressive effect on the host,
adversely affecting. host-bacterial interactions, and this alteration may be due to
changes in the composition of subgingival plaque. Smoking may also provide a
conducive environment for some of the periodontopathic species in the plaque and
may be one reason why smoking is a risk factor in periodontal disease development.
(Cawson, 2002)
15
Smoking exerts a strong, chronic, and dose-dependent suppressive effect on
gingival bleeding on probing. Bleeding on probing was less evident in smokers than
nonsmokers, indicating its effect on gingival blood vessels. The mechanism by which
smoking suppresses gingival bleeding is not understood exactly. On the basis of the
observation that smokers may present with a lower level of gingival inflammation, it
has been speculated that the gingival blood flow in smokers may be less in
comparison to non smokers. This would also induce a decreased local host response.
So, smoking is thought mainly to affect the periodontal tissues by way of the vascular
and immunological response of the body. (Slootweg PJ. 2007)
2.3.1 Toxicity of Tobaco Smoking
Tobacco smoking is an addictive habit first introduced into Europe. Smoking
is now recognized as the most important cause of preventable death and disease.
Currently, the most of adult population smoke cigarettes. The number of cigarette
smokers is slowly declining, but those who do smoke are smoking more. However,
nowadays, the smokers are changing to lower-tar brands. Consumption is rising in
developing countries, particularly where tobacco production bring great economic
benefits, and it will probably continue to rise for the foreseable future. (Slootweg PJ.
2007)
Hundreds of different compounds have been identified in tobacco smoke and
some occur in concentrations judged to be harmful to health. Some of these
substances are indisputably carcinogenic, and smoking has been implicated in the
aetiology of oral neoplasia . Tobacco smoke also contains such noxious substances as
benzanthracene and hydrogene cyanide, which undoubtedly have anti-bacterial
properties. Among the substances found in tobacco smoke is the alkaloid nicotine,
which appears to be responsible for the dependence that characterizes the smoking
habit . During smoking, nicotine is rapidly absorbed into the bloodstream, where 30%
remains in its free form. It is highly lipid-soluble and readily penetrates cell
membranes. Nicotine has actions on almost all the organs of the body. (Calsina 2002)
16
Nicotine is considered the most pharmacologically active compound in
tobacco smoke. Most is absorbed through the lung alveoli, but nicotine can also be
absorbed, though more slowly, through the oral mucosa insufficient quantities to have
a pharmacological effect. Nicotine has pronounced effects on the cardiovascular
system. During smoking it increases the heart rate, cardiac output, and blood pressure
by autonomic stimulation, which also effects peripheral vasoconstriction . There is
also evidence that nicotine acts directly on blood vessels and capillaries to produce
vasoconstriction.(Calsina 2002)
For the last few decades, dentists and dental researches have become more
aware of the critical role of smoking on the incidence and severity of periodontal
disease and smoking is now considered a risk factor in periodontal disease. There is a
long history of association between tobacco smoking and periodontal disease. In
1983, Ismail et al. analyzed smoking and periodontal disease and found that after
adjusting for potential confounding variables such as age, oral hygiene, gender and
socioeconomic status, smoking remained a major risk indicator for periodontal
diseases. Locker and Leake found that among Canadians, smoking was one of the
most consistent predictors of periodontal disease experience. (Calsina 2002)
2.3.2 Plaque Formation
The early studies that examined the relation between smoking and oral
cleanlines consistently found that smokers had poorer oral hygiene than non-
smokers . Macgregor measured the area of stained plaque, and the proportion of
gingival margin in contact with plaque in 64 smokers and 64 non-smokers, matched
for age and sex. In both sexes, smokers had significantly more plaque than non-
smokers, and there was a trend towards increased plaque deposits with increasing
cigarette consumption. However, others have reported contrary findings.
Feldman , in the study of periodontal measures, found significantly less plaque in
smokers than in nonsmokers.(Haber 2000)
Bergstrom and Eliasson similarly found no difference in mean Pl index scores
amongst 285 musicians (31% smokers and 69% non-smokers). Bergstrom and Preber
17
studied the rate of plaque growth in 20 dental students, 10 of whom were smokers,
and 10 non-smokers. Again, there was no quantitative difference between the growth
rates of plaque in smokers and non-smokers.(Haber 2000)
Smokers had more calculus than non-smokers, but the effect of smoking was
independent of the amount of calculus present. There have been consistent reports of
more calculus in smokers than in non-smokers from the earliest epidemiological
studies . Some authors reported that significantly more pipe smokers than cigarette
smokers had supragingival calculus. This might be because the pH of pipe smoke is
higher than that of cigarette smoke, and because pipe smokers circulate the smoke
around the mouth, whereas cigarette smoke tends to be inhaled. Moreover, the
smoking cycle is much longer in pipe smokers than in cigarette smokers, causing pipe
smokers to salivate more.(Luzzi 2004)
Reports that calculus formation is more abundant in smokers may be due to
the increased salivary flow rates. There is an increased calcium concentration in fresh
saliva in smokers following smoking . Nicotine affects the exocrine glands by an
initial increase in salivary and bronchial secretions that are followed by inhibition of
the secretions. The calcium phosphates found in supragingival calculus are in the
main derived from the saliva. The organic components may also arise from this
source, the proteins and polypeptides constituting the major fraction. The increased
amount of calculus found in smokers might therefore be due to an effect of tobacco
smoke upon properties of saliva.(Haber 2000)
2.3.3 Smoking and Gingival Inflammation
Gingival inflammation which develops through several phases, so that it
further affects the other parts of parodont, and finally turns into periodontitis. The
changes at the level of blood vessels appear as the first manifestations of gingival
inflammation (initial lesion). There is dilatation of capillaries and increase of blood
flow. In the early lesion, the initial lesion are becoming more marked, inflammatory
infiltrate also increases, which clinically brings about the enlargement of gingiva.
This is followed by changes in the cell population, with increasing in the number of
18
lymphocytes and macrophages. Developed lesion occurs as the consequence of dental
plaque persistence, when some of the bacteria may penetrate into the host tissue.
Perivascular accumulation of chronic inflammatory cells is evident in this stage. The
increasing number of cells in the chronic inflammatory content is followed by the loss
of collagen in the affected connective tissue. However, in this stage, there is still no
loss of the bone or connective tissue
attachment. (Slootweg PJ. 2007)
Smoking does not normally lead to striking gingival changes. A reduction in
clinical signs of gingivitis has been reported in smokers and this effect has been
shown to be independent of plaque levels. Heavy smokers may have greyish
discoloration and hyperkeratosis of the gingiva: an increased number of keratinized
cells has been found in the gingiva of smokers. Changes in the epithelium were
described as keratotic, hyperkeratotic and hyperplastic. Smoking has long been
considered an etiologic factor in acute necrotizing ulcerative gingivitis (ANUG).
Rowland in a series of studies determined that tobacco smoking was a factor in
ANUG and that with the increase in the use of tobacco there was an increase in
frequency of ANUG. The tar in the smoke exerted a direct irritating effect on the
gingiva giving rise to gingivitis, and that nicotine could caused contraction of the
capillaries. (Slootweg PJ. 2007)
Bleeding from the gum margin is an important early symptom of gingivitis,
and gingival bleeding on probing is now widely used in clinical examination as a
means of identifying active lesions in periodontal disease. Although smoking is
known to produce peripheral vasoconstriction, in some subjects this is preceded by
vasodilatation. In any particular instance, the effect produced is probably related to
the degree of inhalation of the tobacco smoke and the rate of nicotine absorption .
Nicotine from cigarette stimulates the sympathetic ganglia to produce
neurotransmitters including catecholamines. These affect the alpha-receptors on
blood vessels which in turn causes vasoconstriction. The vasoconstriction of
peripheral blood vessels caused by smoking can also effect the periodontal tissue as
smokers have less overt signs of gingivitis than nonsmokers and clinical signs of
19
gingival inflammation such as redness, bleeding and exudation are not as evident in
smokers. The vasoconstrictive actions of nicotine may be responsible for the
decreased gingival blood flow, have found less gingival bleeding in smokers than in
non-smokers, due to vasoconstriction of gingival vessels, but may also be attributable
to the heavier keratinization of the gingivae in smokers.(Cawson 2002)
More recently Palmer and colleagues measured gingival blood flow, using a
laser Doppler technique, and their data did not support the view that smoking
compromised blood flow in the periodontal tissues. Tobacco use has also been
associated with reduced permeability of peripheral blood vessels (34). While there
might be some controversy regarding the effect of tobacco consumption on the
gingival vasculature, the clinical relevance is clear. Prolonged and heavy smoking can
reduce gingival bleeding and therefore mask the clinical marker of bleeding on
probing often used by dentists to monitor periodontal health. (Cawson 2002)
2.3.4 Smoking and Periodontal Disease
Periodontitis is defined as "inflammatory disease of supportive tissue of teeth
caused by specific microorganisms which lead to progressive destruction of
periodontal membrane and alveolar bone, with formation of periodontal pockets and
gingival recession. Opinions have been divided about the effect of smoking on
chronic inflammatory periodontal disease. Earlier reviews of the epidemiology of
periodontal disease concluded that smoking was a possible causative factor. (Calsina,
2002)
Few studies have conclusively demonstrated any relevant microbiological
changes in the periodontal tissues attributable to smoking. Some authors using self-
reported smoking data, investigated the relationship between periodontal pathogens
and cigarette consumption. They reported an increased risk for smokers to have
subgingival infection with Porphyromonas gingivalis although this was not found to
be statistically significant. In this same study the investigators found smokers were 3
times more likely to harbor A. actinomycetemcomitans.
20
Many authors investigated the relationship between cigarette smoking and the
prevalence of periodontal pathogens using polymerase chain reaction techniques. In
this study, which included equal numbers of smoking and non-smoking subjects with
generalized aggressive periodontitis, the investigators could find no significant
differences in the occurrence of any of the pathogenic species which included
Porphyromonas gingivalis, Prevotella intermedia, Tanarella forsythensis,
Actinobacillus actinomycetemcomitans and Tanarella denticola. (Calsina, 2002)
Young smokers diagnosed with aggressive forms of periodontitis were shown
to have more affected teeth and a higher mean loss of periodontal attachment than
non-smokers with these conditions. Cigarette smokers had significantly greater
probing depths and bone loss than non-smokers although no difference was found in
relation to tooth mobility. Bergstrom et al. found smokers not only to have
significantly increased probing depths and alveolar bone loss, but also increased tooth
mobility. Some studies have also highlighted the dose relationship between the effect
of cigarette consumption and periodontal attachment loss. Relationship between
alveolar bone loss and tobacco consumption. The findings when they investigated the
relationship between cigarette smoking and bone loss in a group of dental hygienists
were suggestive of an effect on alveolar bone that was independent of plaque levels.
They also reported that this relationship was age-related, suggesting that progression
was more significant in younger smokers.(Feldman, 2008)
Nicotine metabolites can concentrate in the periodontium and their effects
include the promotion of vasoconstriction, and the impairment of the functional
activity of polymorphs and macrophages. The numbers of neutrophils in peripheral
blood are also increased by tobacco use and their migration through capillary walls.
The polymorphonuclear leukocyte (PMN) is the most abundant phagocyte found at
the site of acute inflammation, and probably has an important role in the defence of
the marginal periodontal tissues against bacterial invasion. Corberand found PMN
morbility to be severely depressed by a solution of tobacco-cmoke concentrate,
although phagocytosis and bactericidal activity were not affected. Smokers have
21
higher blood PMN counts than do non-smokers and chemotaxis of PMN s from
smokers was suppressed relative to nonsmokers. (Feldman, 2008)
Alani et al. reported lower levels of both salivary elastase and neutrophils in
the oral cavity in smokers with periodontitis. Their study demonstrated that oral
elastase and neutrophil counts are lower in smokers compared with nonsmokers with
similar levels of periodontal disease. Their results also suggest that these values
return to non-smoking levels after smoking cessation. The passage of fluid through
the junctional epithelium into the gingival crevice is markedly increased in gingival
inflammation and resembles an inflammatory exudate. It contains leukocytes and
plasma proteins, and probably plays an important role in the deffence of the
gingival tissues against bacterial attack. (Cawson, 2002)
Smoking appears to reduce the flow of this gingival fluid exudate. Bergstrom
and Preber studied 10 smokers and 10 non-smokers over a 4-week period during
which the subjects absained from all oral hygiene measures. They found that the
degree of gingival redness,the occurrence of bleeding from gingival margin, and the
gingival fluid exudate all increased during the experimental period. It should also be
noted that a significant genetic component has been identified in relation to
aggressive periodontitis and the combined interaction of cigarette smoking and
various genetic polymorphisms might also contribute to disease status in young
adults.(Cawson, 2002)
2.4 RELATION OF IMMUNE WITH CARIES
2.4.1 Dentinal Fluid and the Deposition of Intratubular Immunoglobulins
Diffusion of noxious stimuli through the dentinal tubules. The finding that
nonvital teeth have a significantly higher bacterial invasion rate than vital human
teeth further supports the protective role of dentinal fluid pressure18
The composition of dentinal fluid is not fully determined, but it is considered
to be serum-derived tissue fluid containing serum proteins and immunoglobulins
(Igs)19. There is a dynamic change of localization and intensity of Igs deposited in
uninfected dentin beneath caries that seems to follow the changes in vascular
22
permeability during inflammation. In the normal pulp, IgG is detected in the
interstitial fluid20,21 and is localized in the dentinal tubules near the predentin22,23.
Beneath shallow caries, IgG1, IgA1, and IgM, but not IgA2, were detected in
uninfected dentinal tubules. In teeth with deep caries, IgG1, IgA1, IgA2, and IgM
were localized in the uninfected dentinal tubules with high intensity23. The possible
protective functions of antibodies in dentinal fluids can be antigen specific or
nonspecific. For example, natural antibodies against Streptococcus mutans in serum 24,25 may diffuse extravascularly into dentinal tubules via the dentinal fluid to react
with bacterial antigens in carious lesions. IgG along with serum-derived proteins such
as albumin or fibrinogen can adhere to dentinal tubules and nonspecifically decrease
the inward diffusion of antigens. On the other hand, products of the degradation of
Igs in dentinal tubules might serve as a nutrient source for the caries pathogens.
Future study of the role of intratubular Igs in the growth of caries bacteria is clearly
needed. The role of complement-mediated bacterial lysis in the initial pulpal response
to caries appears to be limited. Although complement in the dentinal fluid may be
activated by immune complexing of antibodies to bacterial antigens, Gram-positive
bacteria, the predominant flora in shallow caries, are resistant to complement lysis 26,27In fact, the strongest association of caries bacteria and complement is found in
plaque, and is much weaker in the hard portion of carious dentin28 . However,
complement by-products such as C3a and C5a could participate ain the initial
response by recruiting and activating leucocytes.
2.5 INNATE EFFECTOR IMMUNE CELLS IN THE DENTAL PULP
The principal innate effector cells in most tissues are neutrophils,
mononuclear phagocytes (monocytes and macrophages), and innate lymphocytes
including NK cells. In the dental pulp, both T cells and immature DCs are considered
important in immunosurveillance as part of the innate response to caries. Possible
interactions between innate immune cells, cytokines, odontoblasts, and neuropeptides
in normal and reversible pulpitis pulps beneath shallow caries are proposed .
Neutrophils and macrophages are professional phagocytes in innate immune
23
responses. Neutrophils may not be important in reversible pulpitis; only a few
neutrophils were observed in pulpal tissues under shallow caries29,30,31, and the
physical barrier of the dentin prevents close contact between neutrophils and bacteria.
Instead, an intriguing phagocytic role for odontoblasts has been suggested 33,34,35.
Tissue macrophages are generally derived from circulating monocytes and show a
high degree of heterogeneity, which is influenced by their microenvironment. For
instance, alveolar macrophages express high titers of pattern recognition receptors
with high cytokine induction, whereas macrophages from the lamina propria of the
gut exhibit high phagocytic and bactericidal activity but weak production of
proinflammatory cytokines36. Activated macrophages are effective killers that
eliminate pathogens in both innate and adaptive immune responses 32, and are also
important in tissue homeostasis, through the clearance of senescent cells, and in
remodeling and repair of tissue after inflammation. Although the characteristics of
macrophages in the healthy dental pulp have not been examined, VEGF, a potent
inducer of angiogenesis and vascular permeability, is secreted when mouse
macrophages are challenged with LTA. Furthermore, the number of macrophages
increases with the progression of caries and is always higher than that of DCs at all
stages of the caries invasion . Therefore, these monocyte-derived macrophages may
be activated in
2.6. CYTOKINES IN INNATE IMMUNITY
The cytokines secreted by innate immune cells include TNF-_, IL-1, IL-12,
interleukin-18 (IL-18), IFN-_, IL-6, and interleukin-10 (IL- 10) (1). TNF-_ and IL-1
act on vascular endothelial cells at the site of infection to induce the expression of
adhesion molecules that promote extravasation of phagocytes during inflammation.
Rapid induction of IFN-_ production from NK cells and resting T cells by IL-12 and
IL-18 directs the subsequent adaptive cellular immune response toward type 137,38(.
IFN-_ activates not only phagocytes and APCs, but also potentiates many of the
actions of TNF-alpha on endothelial cells, which include T-cell adhesion and
24
extravasation to sites of infection . IFN-_ is also secreted by activated T cells and is
important in the adaptive immune response39 .
IL-10, mainly produced by activated macrophages, inhibits functions of
macrophages and DCs that control innate immune reactions and cell-mediated
immunity. IL-6 is secreted by various cell types in response to microbes or cytokines,
particularly IL-1 and TNF-_. IL-6 stimulates the synthesis of acute-phase proteins
and neutrophils from bone marrow progenitors. Small amounts of mRNA expression
of IL- 1_, IL-1_, IL-4, IL-6, IL-10, IL-18, and IFN-_ were detected in normal or
asymptomatic pulps40,41.Future studies of comprehensive cytokine gene expression in
pulps from normal and enamel caries teeth are warranted to understand their role in
the initial immune response.
2.6.1. Neuropeptides, Neurogenic Inflammation, and Caries
Sensory neuropeptides such as calcitonin gene-related peptide (CGRP),
substance P (SP), and neurokinin A (NKA) are detected in normal human pulps, with
a higher concentration of CGRP than SP.
Figure 2.2 Caries and Immune system
25
NKA. Arterioles in the dental pulp are heavily innervated by CGRPand SP-
containing fibers42. Significant increases in innervation (nerve sprouting) and
neuropeptide concentration were observed following pulpal injury. Increased
concentrations of neuropeptides were detected in painful pulpitis samples43,44. In fact,
SP expression was significantly greater in painful pulpitis specimens45 than in grossly
carious asymptomatic specimens. Neuropeptides from sensory nerves participate in
neurogenic inflammation46,47
These vasoactive neuropeptides, released upon stimulation via an axon reflex
mechanism, cause increased pulpal blood flow and vascular permeability. For
example, CGRP is the prime mediator of neurogenic vasodilatation of arterioles. SP
and NKA are the main messengers of postcapillary venular permeability. Although
CGRP per se does not cause protein leakage, it is able to enhance the exudative
response to SP and NKA. The end result of neurogenic inflammation is a transient
increase of interstitial tissue pressure and outward flow of dentinal fluid, which is
considered protective as discussed above. If the pulp is healthy, excess interstitial
fluid resulting from transient neurogenic inflammation will be absorbed into the
circulatory or lymphatic system via edema-preventing mechanisms. If pulp is not
capable of resolving the increased tissue pressure, increased levels of neuropeptides
and persistent edema could contribute to pain and local necrosis. The unique
intratubular localization of nerve fibers and their involvement in the outward flow of
dentinal fluid from neurogenic inflammation make the neural component an
importantpart of the initial vascular response to caries.
2.6.2. T Cells in Innate Immunity in the Dental Pulp
The predominant T-cell type in the normal pulp is the memory CD8_ T cell,
but its functions in the normal pulp remain undefined. The well-known functions of
CD8_T cells are to kill virusinfected or transformed host cells via induction of
apoptosis or perforin production, and to produce IFN-_ to augment phagocytosis. The
mech-anism that preferentially attracts CD8_ T cells in normal healthy pulp was not
understood until recently. Studies demonstrated that CD8_ T-cells exhibited higher
26
migratory capacity across endothelial cells than CD4_T cells49,50, and memory CD8_T
cells can migrate into tissue sites distant from the site of their initial antigen
challenge51,52
Therefore, an immune surveillance role of CD8_ T cells was proposed 53,54.
The recruitment of T cells to non inflammed human skin is partially from a basal
expression of E-selectin, chemokine CCL17, and intercellular adhesion molecule-1
(ICAM-1) in dermal vessels55. Interestingly, endothelium in the healthy dental pulp
exhibits low levels of E-selectin and P selectin56. Whether CD8_T cells in normal
pulp tissue are part of the immune surveillance system remains to be determined.
Figure 2.3 Immune surveillance system
2.7 TUBERCULOSIS
Tuberculosis, or TB, is an infection caused by a bacteria that usually involves
the lungs (pulmonary TB) but could affect other parts of the body (extra-pulmonary
TB); for example, brain, lymph nodes, kidneys, bones, joints, larynx, intestines or
eyes. TB infection may result after close contact with a person who has TB disease.
TB infection is determined by a significant reaction to the Mantoux skin test with no
27
symptoms of TB and no TB bacteria found in the sputum. Sputum is mucous or
phlegm coughed up from the lungs. TB disease is characterized by the appearance of
symptoms, a significant reaction to the Mantoux skin test and identification of TB
bacteria. TB may last for a lifetime as an infection, never developing into disease.
However, individuals with TB infection are at considerable risk of developing TB
disease, particularly during the first year after acquiring the infection. Additionally,
individuals with weakened immune systems, such as people with HIV, are at high
risk of developing TB disease if TB infection is untreated.
2.7.1 Spread Of Tb
M. Tuberculosis is carried in airborne particles, called droplet nuclei, of 1–5
microns in diameter. Infectious droplet nuclei are generated when persons who have
pulmonary or laryngeal TB disease cough, sneeze, shout, or sing. Depending on the
environment, these tiny particles can remain suspended in the air for several hours.
M. Tuberculosis is transmitted through the air, not by surface contact, clothes, dishes,
floors or furniture. Transmission occurs when a person inhales droplet nuclei
containing M. Tuberculosis, and the droplet nuclei traverse the mouth or nasal
passages, upper respiratory tract, and bronchi to reach the alveoli of the lungs.
28
Figure 2.4. Transmission of Tuberculosis in human
2.7.2 The Difference Between Tb Infection And Tb Disease
Latent TB infection (LTBI) does not cause a person to feel sick, and there are
no symptoms. Tuberculin skin tests (TSTs) or interferon gamma release assay
(IGRA) blood tests are used to diagnose LTBI. A positive result means that TB
infection is present. Treatment for LTBI is effective in preventing persons with LTBI
from developing TB disease. Nine in ten people with a normal immune system with
LTBI will never develop TB disease. However, one in ten of those infected will
develop TB disease at some time in their lives, though the risk is lower if they receive
preventive therapy. About half of these will develop TB disease within the fi rst 2
years after they become infected. There is no way to determine which people with
LTBI will later get sick with TB disease. The following persons are at high risk for
progressing from LTBI to TB disease:
• Persons infected with HIV and other diseases, such as diabetes and renal condi-tions
that require dialysis, that weaken the immune system
• Persons infected with M. tuberculosis within the previous 2 years
• Infants and children <4 years old
29
• Persons who receive medical treatments, such as certain cancer treatments or pro-
longed steroid use, that weaken the immune system
• Persons with a history of untreated or inadequately treated TB disease
2.7.3 TB Disease
Most TB disease occurs in the lungs, but about 15% occurs in other parts of
the body (e.g., bone, eye, and brain). General symptoms of pulmonary TB include:
• Cough
• Fever
• Night sweats
• Fatigue
• Unexplained weight loss
• Hemoptysis (bloody sputum)
Without treatment, a person with TB disease will get sicker. A person with
untreated pulmonary TB disease of the lungs or larynx will also become more
contagious. Untreated TB can become a life-threatening disease; however, with
effective and complete treat-ment,TB can be cured. A person with a cough lasting 3
or more weeks along with any other symptoms of TB disease (fever, night sweats,
fatigue, unexplained weight loss, hemoptysis [ bloody spu-tum]) should be evaluated
by a healthcare provider as soon as possible. If TB disease is diagnosed or suspected,
treatment will be prescribed.
2.7.4 When TB is Infectious
With rare exceptions, TB is infectious only when it occurs in the lungs or
larynx. TB that occurs elsewhere in the body is usually not infectious, unless the
person also has TB in the lungs or larynx at the same time. In general, a person with
suspected or confi rmed TB disease of the lungs or larynx should be considered
infectious until the person has :
30
1. Had three negative acid-fast bacilli (AFB) sputum smear results obtained 8-24
hours apart, with at least one being an early morning specimen (an AFB sputum
smear is a type of medical test used in the diagnosis of TB); and
2. Shown to have clinical improvement as a result of antituberculosis treatment (for a
minimum of 2 weeks) that is based on susceptibility results,
3. Been determined to be noninfectious by a physician knowledgeable and experi-
enced in managing TB disease. A person who has met all three of the above
conditions must continue to take TB medications as prescribed and continue to
receive medical care for TB.
2.7.5 Pathogenesis Of Tb
Route and site of infection : Mycobacterium tuberculosis is an obligatory
aerobic, intracellular pathogen, which has a predilection for the lung tissue rich in
oxygen supply. The tubercle bacilli enter the body via the respiratory route. The
bacilli spread from the site of initial infection in the lung through the lymphatics or
blood to other parts of the body, the apex of the lung and the regional lymphnode
being favoured sites. Extrapulmonary TB of the pleura, lymphatics, bone,
genitourinary system, meninges, peritoneum, or skin occurs in about 15 percent of
TB patients.
Events following entry of bacilli: Phagocytosis of M.tuberculosis by alveolar
macrophages is the first event in the host-pathogen relationship that decides outcome
of infection. Within 2 to 6 week of infection, cell-mediated immunity (CMI)
develops, and there is an influx of lymphocytes and activated macrophages into the
lesion resulting in granuloma formation. The exponential growth of the bacilli is
checked and dead macrophages form a caseum. The bacilli are contained in the
caseous centers of the granuloma. The bacilli may remain forever within the
granuloma, get reactivated later or may get discharged into the airways after
enormous increase in number, necrosis of bronchi and cavitation.
Fibrosis represents the last-ditch defense mechanism of the host, where it
occurs surrounding a central area of necrosis to wall off the infection when all other
31
mechanisms failed. In our laboratory, in guineapigs infected with M. tuberculosis,
collagen, elastin and hexosamines showed an initial decrease followed by an increase
in level. Collagen stainable by Van Gieson’s method was found to be increased in the
lung from the 4th week onwards.
2.7.6 Evasion of host immune response by M. Tuberculosis
M. Tuberculosis is equipped with numerous immune evasion strategies,
including modulation of antigen presentation to avoid elimination by T cells. Protein
secreted by M. Tuberculosis such as superoxide dismutase and catalase are
antagonistic to ROI. Mycobacterial components such as sulphatides, LAM and
phenolic glycolipid I (PGL-I) are potent oxygen radical scavengers. M. Tuberculosis
infected macrophages appear to be diminished in their ability to present antigens to
CD4+ T cells, which leads to persistent infection. Another mechanism by which
antigen presenting cells (APCs) contribute to defective T cell proliferation and
function is by the production of cytokines, including TGF-β, IL-10 or IL-6. In
addition, it has also been reported that virulent mycobacteria were able to escape
from fused phagosomes and multiply.
2.7.7 Host immune mechanisms in TB
Innate immune response: The phagocytosis and the subsequent secretion
of IL-12 are processes initiated in the absence of prior exposure to the antigen and
hence form a component of innate immunity. The other components of innate
immunity are natural resistance associated macrophage protein (Nramp),
neutrophils, natural killer cells (NK) etc. Our previous work showed that plasma
lysozyme and other enzymes may play an important role in the first line defense, of
innate immunity to M. tuberculosis.The role of CD-1 restricted CD8+ T cells and
non-MHC restricted T cells have been implicated but incompletely understood.
Nramp
32
Nramp is crucial in transporting nitrite from intracellular compartments such
as the cytosol to more acidic environments like phagolysosome, where it can be
converted to NO. Defects in Nramp production increase susceptibility to
mycobacteria. Newport et al 44 studied a group of children with susceptibility to
mycobacterial infection and found Nramp1 mutations as the cause for it. Our
laboratory study on pulmonary and spinal TB patients and control subjects
suggested that NRAMP1 gene might not be associated with the susceptibility to
pulmonary and spinal TB in the Indian population.
Neutrophil
Increased accumulation of neutrophil in the granuloma and increased
chemotaxis has suggested a role for neutrophils 46. At the site of multiplication
of bacilli, neutrophils are the first cells to arrive followed by NK cells, γ / δ cells and
α / β cells. There is evidence to show that granulocyte-macrophage colony
stimulating factor (GM-CSF) enhances phagocytosis of bacteria by neutrophils.
Human studies have demonstrated that neutrophils provide agents such as defensins,
which is lacking for macrophage-mediated killing. From our source have shown that
neutrophils can bring about killing of M. tuberculosis in the presence of calcium
under in vivo conditions.
Natural killer (NK) cell
NK cells are also the effector cells of innate immunity. These cells may
directly lyse the pathogens or can lyse infected monocytes. In vitro culture with
live M. tuberculosis brought about the expansion of NK cells implicating that they
may be important responders to M. Tuberculosis infection in vivo. During early
infection, NK cells are capable of activating phagocytic cells at the site of
infection. A significant reduction in NK activity is associated with multidrug-resistant
TB. NK activity in BAL has revealed that different types of pulmonary TB are
accompanied by varying degrees of depression. IL-2 activated NK cells can bring
about mycobactericidal activity in macrophages infected with M . avium complex
33
(MAC) as a non specific response. Apoptosis is a likely mechanism of NK
cytotoxicity. NK cells produce IFN-γ and can lyse mycobacterium pulsed target cells.
From the research demonstrate that lowered NK activity during TB infection is
probably the effect and not the cause’for the disease as demonstrated by the follow up
study. Augmentation of NK activity with cytokines implicates them as potential
adjuncts to TB chemotherapy.
The Toll-like receptors (TLR)
The recent discovery of the importance of the TLR protein family in immune
responses in insects, plants and vertebrates has provided new insight into the link
between innate and adaptive immunity. From the research Showed that a human
homologue of the Drosophila Toll protein signals activation of adaptive immunity.
The interactions between M. tuberculosis and TLRs are complex and it appears that
distinct mycobacterial components may interact with different members of the TLR
family. M. Tuberculosis can immunologically activate cells via either TLR2 or TLR4
in a CD 14-independent, ligand-specific manner.
2.7.8 Acquired immune response
Humoral immune response: Since M. tuberculosis is an intracellular pathogen,
the serum components may not get access and may not play any protective role.
Although many researchers have dismissed a role for B cells or antibody in protection
against TB, recent studies suggest that these may contribute to the response to
TB. Mycobacterial antigens inducing humoral response in humans have been studied,
mainly with a view to identify diagnostically relevant antigens. Several protein
antigens of M. Tuberculosis have been identified using murine monoclonal
antibodies. The immunodominant antigens for mice include 71, 65, 38, 23, 19, 14 and
12kDa proteins. The major protein antigens of M. leprae and M. Tuberculosis have
been cloned in vectors such as Escherichia coli. Not all the antigens identified based
on mouse immune response were useful to study human immune response. In our
laboratory a number of M. Tuberculosis antigens have been purified and used for
34
diagnosis of adult and childhood TB. Combination of antigens were also found to be
useful in the diagnosis of HIV-TB. Detection of circulating immune complex bound
antibody was found to be more sensitive as compared to serum antibodies. The
purified antigens were evaluated for their utility in diagnosing infection.
2.7.9 Cellular Immune Response
T cells
M. tuberculosis is a classic example of a pathogen for which the protective
response relies on CMI. In the mouse model, within 1 week of infection with virulent
M. tuberculosis, the number of activated CD4+ and CD8+ T cells in the lung draining
lymphnodes increases. Between 2 and 4 week post-infection, both CD4+ and CD8+ T
cells migrate to the lungs and demonstrate an effector/memory phenotype
(CD44hiCD45LoCD62L-); approximately 50 percent of these cells are CD69+. This
indicates that activated T cells migrate to the site of infection and are interacting
with APCs. The tuberculous granulomas contain both CD4+ and CD8+ T cells that
contains the infection within the granuloma and prevent reactivation.
CD4 T cells
M. tuberculosis resides primarily in a vacuole within the macrophage, and
thus, major histocompatibility complex (MHC) class II presentation of
mycobacterial antigens to CD4+ T cells is an obvious outcome of infection. These
cells are most important in the protective response against M. tuberculosis. Murine
studies with antibody depletion of CD4+ T cells, adoptive transfer, or the use of gene
disrupted mice have shown that the CD4+ T cell subset is required for control of
infection.
In humans, the pathogenesis of HIV infection has demonstrated that the loss
of CD4+ T cells greatly increases susceptibility to both acute and reactivation TB. The
primary effector function of CD4+ T cells is the production of IFN-γ and possibly
other cytokines, sufficient to activate macrophages. In MHC class II-/- or CD4-/-
mice, levels of IFN-γ were severely diminished very early in infection. NOS2
35
expression by macrophages was also delayed in the CD4+ T cell deficient mice, but
returned to wild type levels in conjunction with IFNγ expression. In a murine model
of chronic persistent M. tuberculosis infection77, CD4 T cell depletion caused rapid
re-activation of the infection. IFN-γ levels overall were similar in the lungs of CD4+
T cell-depleted and control mice, due to IFN γ production by CD8+ T cells.
Moreover, there was no apparent change in macrophage NOS2 production or activity
in the CD4+ T cell-depleted mice. This indicated that there are IFN-γ and NOS2-
independent, CD4+ T cell-dependent mechanisms for control of TB. Apoptosis or
lysis of infected cells by CD4+ T cells may also play a role in controlling infection.
Therefore, other functions of CD4+ T cells are likely to be important in the protective
response and must be understood as correlates of immunity and as targets for vaccine
design.
CD8 T cells
CD8+ cells are also capable of secreting cytokines such as IFN-γ and IL-4 and
thus may play a role in regulating the balance of Th1 and Th2 cells in the lungs of
patients with pulmonary TB. The mechanism by which mycobacterial proteins gain
access to the MHC class I molecules is not fully understood. Bacilli in
macrophages have been found outside the phagosome 4-5 days after infection, but
presentation of mycobacterial antigen by infected macrophages to CD8 T cells can
occur as early as 12 h after infection. Reports provide evidence for a
mycobacteria-induced pore or break in the vesicular membrane surrounding the
bacilli that might allow mycobacterial antigen to enter the cytoplasm of the infected
cell.
γ/δ T-cells in TB
The role of γ/δ T cells in the host response in TB has been incompletely
worked out. These cells are large granular lymphocytes that can develop a dendritic
morphology in lymphoid tissues; some γ/δ T cells may be CD8+. In general, γ/δ T
cells are felt to be non-MHC restricted and they function largely as cytotoxic T cells.
36
Animal data suggest that γ / δ cells play a significant role in the host
response to TB in mice and in other species, including humans. M. tuberculosis
reactive γ / δ T cells can be found in the peripheral blood of tuberculin positive
healthy subjects and these cells are cytotoxic for monocytes pulsed with
mycobacterial antigens and secrete cytokines that may be involved in granuloma
formation. Studies demonstrated that γ/δ cells were relatively more common (25 to
30% of the total) in patients with protective immunity as compared to patients with
ineffective immunity. Our study in childhood TB patients showed that the
proportion of T cells expressing the γ/δ T cell receptor was similar in TB patients and
controls. Thus γ/δ cells may indeed play a role in early immune response against TB
and is an important part of the protective immunity in patients with latent infection.
2.8 MALNUTRITION
The World Health Organization defines malnutrition as "the cellular
imbalance between the supply of nutrients and energy and the body's demand for
them to ensure growth, maintenance, and specific functions." Put otherwise,
malnutrition may be seen as the antithesis to good nutrition or ‘well-nutrition’.
2.8.1 Defining BMI
Except for extremely muscular individuals, BMI is a relatively accurate
measure of an individual’s body fat content. The higher a person’s BMI, the greater
the health risks. For example, conditions such as diabetes, hypertension,
cardiovascular disease, and increased cancer risk are directly related to the degree of
obesity as measured by BMI. Conversely, low BMI (less than 19 kilograms per
square meter [kg/m²]) is also associated with increased morbidity and mortality; the
lower the BMI, the greater the risk.
BMI is calculated using a person’s height and weight and the following
equation: BMI = (weight in pounds) ÷ 2.2 = kg/m [height in inches ÷ 39.6]².
37
Although BMI is a clean, precise mathematical calculation, the concept of
malnutrition is inexact and somewhat subjective. First, there are no authoritative
definitions of malnutrition or the severity of malnutrition, although some are expected
soon from the American Dietetic Association. Furthermore, the diagnosis of
malnutrition is a complicated, multi factorial clinical determination that requires more
than simply finding a low albumin or pre albumin.
Malnutrition includes such criteria as:
»»Physical findings like emaciation, cachexia or muscle/adipose wasting, or atrophy
(e.g., temporal wasting, thenar atrophy)
»»Presence of risk factors such as cancer, chemotherapy, AIDS, alcoholism, end-
stage disease, mal absorption syndromes, or other gastrointestinal and pancreatic
disorders
»»Biochemical markers including low albumin, pre albumin, cholesterol, transferin,
blood urea nitrogen/creatinine ratio, and/or anemia
»»Recent or progressive weight loss, low body weight, or low BMI
Table 2.2 Level condition of BMI for human
The ultimate diagnosis of malnutrition and its severity depends upon the
physician’s clinical judgment based on a constellation of the above findings in each
individual case. No particular finding is required or definitive. As summarized in the
38
“General classification of malnutrition” table, the severity of malnutrition should be
classified as mild, moderate, or severe. Therefore, “unspecified” malnutrition really
has no clinical meaning, but it is a coding convention used when the severity of
malnutrition has not been documented by a provider.
Table 2.3 General classification of malnutrition condition
2.8.2 Malnutrition Leads to a Vicious Cycle of Immune Dysfunction and
Diseases
Although infectious illnesses vary in severity and duration, they all put a
physiological and biochemical burden on the immune system. In order to withstand
this metabolic challenge, the function of cells building the immune system needs to
be supported by a continuous supply of nutrients.
Malnutrition, unhealthy diets deficient in micronutrients, and micronutrient
imbalances can disrupt the function of various immune system components. This
weakens immune defense, decreasing its effectiveness in the elimination of pathogens
and making us vulnerable to various diseases. In addition, the illness itself, whether
symptomatic or asymptomatic, is always accompanied by the loss of many nutrients
in the body, which further aggravates already existing nutrient deficiencies.
39
If these nutrient losses are not adequately and quickly addressed, the vulnerability to
other diseases increases, thereby triggering a spiral of diseases often impossible to
control.
Figure 2.5 The Leading Cause of Immune Deficiency Diseases; Malnutrition triggers
2.8.3 Nutrients Support All the Critical Steps of Our Immunity
Good nutrition and an optimum supply of micronutrients are important in
supporting various cellular functions critical for an effective immune response.
Among them, nutrients are needed to support:
• Non-specific defense components, which are needed to defend against any type of
infection. These include the synthesis of interferon and the optimum function of
phagocytic cells.
• Protective anti-microbial barriers created by the skin, mucus membranes, tears,
saliva, gastric juice, etc. An optimum supply of nutrients, in particular those
supporting protein synthesis, is also important for normalizing serum proteins, some
of which function as anti-microbial agents (e.g. lysozyme).
• Production of antibodies and optimization of cell-mediated immunity. Based on its
functions, the immune system is divided into the cellular system and humoral system.
40
The humoral system consists of B-lymphocytes, plasma cells, and specific immune
globulins that produce antibodies. The cellular system is the major defense
mechanism that the body uses to combat various viral and bacterial infections, as well
as fungal and parasitic diseases. This cell-mediate immunity is built and depends on
the function of T-lymphocytes – a subset of white blood cells produced in the bone
marrow – that requires the proper function of the thymus for their functional maturity.
Impaired T-lymphocyte response has been associated with general protein
malnutrition, which is usually accompanied by a deficiency of vitamins and other
micronutrients in the body.
2.8.4 Older people may be especially vulnerable to malnutrition
The prevalence of malnutrition rises with age. Many changes associated with
the process of ageing may exacerbate malnutrition – although malnutrition is by no
means an inevitable facet of ageing. Older patients may be at greater risk of not being
able to recover from malnutrition. Malnutrition may be secondary to certain
conditions (disease-related malnutrition), such as cancer, arthritis, diabetes, or
emphysema. It is also a condition in its own right. Common risk factors for
malnutrition are summarised below.
Calcium, vitamin D, vitamin B12 and folate are micronutrients frequently
under consumed in older people. These deficiencies induce a decreased immune
response that could negatively impact on quality of life and health status.
41
Table 2.4 Risk factors for malnutrition
2.8.5 Physical factors and malnutrition
Weight loss can result from physical factors such as dysphagia, poor dentition,
anorexia, altered taste and smell, and constipation (Table 1). Poor chewing and
swallowing ability can significantly impact the type and amount of food consumed.
Texture modified diets rarely have the same nutritional quality of a full diet, which
can send dysphagic patients on a continuous downward spiral leading to protein
energy malnutrition.
42
2.8.6 Social factors and malnutrition
Poor appetite, inappropriate food choices, food aversion, decreased energy
and inability to self feed can result from social factors and can place individuals at
risk of malnutrition. Malnutrition is more common for institutionalized elderly than
independently living elderly – with more than 50% of people living in hospitals or
nursing homes affected.15 Obtaining adequate vitamin D can be a challenge for
institutionalized and house bound older people who have limited sun exposure.
Living or eating alone causes older people to eat less and increases their risk
of compromised nutritional status, with men being particularly vulnerable. Many
older people living alone exist on a ‘tea and toast’ diet that is low in energy, protein
and micronutrients. Taste changes often result in a dislike and avoidance of nutrient
dense foods (eg. lean meat). These factors place the individual at a higher risk of
malnutrition and micronutrient deficiencies.
Restrictive diets due to personal preference, cultural or religious beliefs, or for
medical purposes (including low cholesterol, low salt, vegetarian, kosher and halal
diets) can increase the risk of protein malnutrition and micronutrient deficiency as
they remove or limit common high protein foods.
2.8.7 Screening for malnutrition
As often the first point of contact of patient care in the community, general
practitioners have the opportunity to identify and assess risk factors leading to
compromised nutritional status in elderly patients. No one standard test or
biochemical marker is used to indicate or diagnose malnutrition in the elderly. A
combination of medical, social, anthropometric, biochemical, clinical and dietary data
are required to thoroughly assess, monitor, evaluate and determine appropriate
nutritional therapy.
The Subjective Global Assessment (SGA) tool is the ‘gold standard’ for
assessing malnutrition in hospitalised elderly due to its simplicity, accuracy and
reliability. The Mini Nutritional Assessment Short Form (MNA-SF) is well validated
for early detection of malnutrition in community dwelling elderly people.
43
Weight alone is inadequate in measuring nutritional status in older people as a
stable weight may mask changes in body composition. Adipose tissue replaces
muscle mass in normal aging (Figure 1) with greater rates being likely in a sick,
elderly population. A body mass index (BMI) range of 22–27 kg/m2 can be used to
determine a healthy weight range in older people. Although age related changes in
body composition can make BMI an unreliable indicator of malnutrition, a BMI <20
kg/m2 is a reasonable threshold to define a high risk of malnutrition.
Figure 2.6 Body composition changes in healthy adult males
2.9 PERIODONTAL DISEASE
Periodontal disease, the most common disease in the world and the leading
cause of tooth loss in adults is a chronic infection that slowly attacks and destroys the
gums and bone that support the teeth (Hafernick, 2000). Symptoms associated with
periodontal disease are sore, inflamed gums that have a tendency to bleed.
Estimations have shown that at least 75 percent of the adult population in America
has some form of periodontal disease (Scheffler, 2000). Adults are not the only group
susceptible to the disease; one-third of children ages 6-11 and two-thirds of
adolescents have some form of periodontal disease (periodontal).
The term periodontal disease usually refers only to plaque related
inflammatory disease of the dental supporting tissues. A wide variety of diseases of
44
the oral mucosa can also affect the gingival occasionally, so that conditions as diverse
as tuberculosis or lichen planus can produce lesions in this area. Such conditions do
not play any significant part in the development of periodontal disease in its
commonly accepted sense. (Cawson, 2002)
Periodontal disease is caused by more than 200 species of bacteria. These
bacteria form masses of sticky film called plaque, which is able to adhere to the
surface of teeth and gums. The bacteria are then nourished by the consumption of
foods, especially sweets. The sugars are metabolized by the bacteria which causes the
secretion of acids, enzymes, and other soft tissue irritants and bone destroyers. When
left untreated, the bacteria begin to spread to areas that are hard to reach with normal
brushing and flossing; for instance, areas below the gum line, thus causing
periodontal disease (periodontal)(Bathesda,2001)
Chronic gingivitis is, with few exceptions, the preliminary stage to the
development of chronic periodontitis, but clinically no sharp dividing line can be
drawn between chronic gingivitis and the onset of periodontitis. Nevertheless, the
distinction is important in that chronic gingivitis can generally be cured by plaque
control. By contrast, loss of bone and tooth support due to chronic periodontitis is
largely irreversible. (Cawson, 2002)
The bone of the alveolar crest shows resorption as demonstrated by the
presence of Hownship’s lacunae sometimes still containing multinucleated
osteoclasts. The epithelial attachment that normally lies in contact with the tooth
enamel has moved downwards to be partly opposite the enamel and the root
cementum or even entirely opposite the root cementum. Resorption of bone and
downward displacement of the epithelial attachment may continue until there is
insufficient periodontal tissue left for adequate fixation of the tooth in the jaw. Caries
may add to the damage caused by periodontitis by attacking the cementum covering
the exposed root surface.( Slootweg PJ, 2007)
45
Figure 2.7 Type of periodontal Disease
46
SMOKING DECREASING IMMUNE SYSTEMDECREASING IMMUNE SYSTEM
ARB (+)
TBC
PLAQUE
BACTERIA
SIGH IN BLOOD VESSEL
TOKSIN OF BACTERIA
INTERRUPTED INSULIN SECRETION
DAMAGE OF PERODONTAL TISSUE
INFLAMMATION OF PERODONTAL TISSUE
DISEASE PERIODONTAL
SNACKINGDIABETESMELITUS (DM)
CARBOHYDRATE BACKWARD IN TEETH
CARIES
HOARD OF FOOD/ OVERFLOW
MALNUTRITION
WEIGHT LOSSDECREASING IMUN SYSTEM
CHAPTER 3
CONCEPTUAL MAPPING
47
CHAPTER 4
DISCUSSION
In this case, a man with 50 years old was being treated in hospital, reffered to
dental clinic for dental treatment especially molar treatment that had cavity and
continous pain and also bleeding. The patient had shortness of breathing for the last 2
weeks with continous chest pain and chronic cough for more than 1 month. Patient
had fever for the last 2 weeks especially in the evening, sweat in the night, loss of
appetite and loss of weight.
Hypothesis : Tubeculosis, Periodontal Disease, Diabetes Mellitus
The Physical Examination Result :
The patient’s profile :
- Work as driver for urban transportation
- Love to eat snack
- A Smoker
- Age : 50 Years old ( Productive’s age level )
Medical’s History :
Was being treated in hospital
- Shortness of breathing for the last 2 weeks with continous chest pain and chronic
cough for more than 1 month.
- Had fever for the last 2 weeks especially in the evening, sweat in the night, loss of
appetite and loss of weight.
Extra Oral : Examination test result for Lymph Gland was normal
Body weight = 46 kg and 160 cm tall, the normal weight should 60 kg
48
Intra Oral :
- Oral Hygiene : bad
- mucosal : looks pale
-Gingival : pain and bleed easily for long time
Status localist:
Blood Glucose = 370 mg/dl
Blood Pressure = 130/80 mmHg ( level Pre-Hipertensi )
Body Temperature = 37,6 0C
Acid Resistant Bacteria Test ( ARB ) = +
The Teeth 16 with deep cavity and feels so pain
Pocket with periodontal probe :
Buccal and lingual = 5 mm
mesial and distal = 5 mm
Panoramic x-ray picture :
Visible tooth 16 with crest alveolar bone resorption and widening of the periodontal
space
From this case, we have found one of the main reasons for this to happen is
smoking. A burning cigarette is a chemical plant that produces over 6700 chemical
components and 4000 have been identified. the component particles are generally
cigarette tar and nicotine. Pulmonary TB is the main entry of germs is by inhalation
of airborne droplets. Only 1-5 micron droplet size that can pass through or penetrate
the airway mucociliary system so as to achieve and lodged in the bronchioles and
alveoli. At this point, the TB bacilli multiply and spread through the lymph and
blood flow without resistance from the host because there is no early immune. Non-
specific inflammatory reaction occurs in the alveoli. Macrophages in the alveoli will
phagosites but most of the TB bacilli are able to kill him so that the bacilli in
49
macrophages can generally survive and breed. TB bacilli are spread through lymph
channels that reach the regional lymph nodes via the blood stream to reach the
various organs of the body as well as a transfer of antigen to lymphocytes. Before
imunity specific form of TB bacilli in the field on lung, kidney, bone and brain easier
to breed. Specific imunity formed is usually strong enough to inhibit further breeding
TB bacilli that TB lesions will heal and no clinical symptoms. TB bacilli during
primary infection takes place nested in the hilar lymph nodes and mediastenum and
can be nested in other lymph nodes. The infection in the gland may take into active
TB within a few years later or never becomes active.
Hipersensitivity some components of M. Tb can be seen in the tuberculin skin
test which usually occurs 2-10 weeks after infection, when it occurs in a cell-
mediated immune response. After the first infection of TB bacilli spread throughout
the body one day will grow and cause a disease. Immunologic response against TB
infection in the form of imunity cellular (cell-mediated immunity) and slow type
hypersensitivity (delayed-type hypersensitivity) an immune response is weak or fails
then there is active TB in individuals infected with M. Tb. Imunity cell causes T
lymphocyte proliferation-Cluster of Differentiation (CD4) and local cytokine
production in response to antigens released M. Tb helper1 T lymphocytes (Th1) T
lymphocytes activate macrophages whereas helper2 (Th2) adds humoral antibody
synthesis and then produce cytokines necrosing factor a (TNF-a) and interferon-g
(INFg). These cytokines will draw blood monocytes and activate TB lesions.
Activated monocytes or macrophages and lymphocytes TCD4 produce lysosomal
enzymes, oxygen radicals, nitrogen intermediate and interleukin-2 (IL-2). Imunity
activate macrophages thereby inhibiting cell replication slow type hipersensitivity
basil inhibit replication by destroying macrophages containing bacilli have not been
active and M. Tuberculosis, also isolate active lesions caused M. Tuberculosis
became dormant, tissue damage, fibrosis, and scarring. Macrophages are activated by
cellular imunity not able to prevent the proliferation of cells in cavity extra basil.
Antigen bacilli released in mass melt. Toxicity dinsing antigen to cause the nearby
airways become necrotic, broken, and it has spread formation cavity basil M.
50
Tuberculosis and mass the liquid to other parts of the lung. Then the mass melting
cause disease to take hold. tissue damage caused by the cellular response to bacillus
M. imunity Tuberculosis or toxin.
On the other side, the smoking effect has some another problems for his body.
Mutans streptococci participate in the formation of biofilms on tooth surfaces. These
biofilms are known as dental plaque(s). Sucrose is required for the accumulation of
mutans streptococci. Initial attachment of mutans streptococci to tooth surfaces, this
attachment is thought to be the first event in the formation of dental plaque. The
mutans streptococcal adhesin (known as antigen I / II) interacts with - galactosides in
the saliva - derived glycoprotein constituents of the tooth pellicle. Accumulation of
mutans streptococci on tooth surfaces in the presence of sucrose, glucosyltransferases
enzymes (GTFs) synthesize extracellular glucans from glucose (after the breakdown
of sucrose into glucose and fructose), and this is thought to be the second event in the
formation of dental plaque. The mutans streptococcal Glucan - binding protein (GBP)
is a receptor - like protein that is distinct from GTFs, and it specifically binds glucans.
GTFs themselves also have a glucan - binding domain and can therefore also function
as receptors for glucans. Mutans streptococci bind pre - formed glucans through GBP
and GTFs, and this gives rise to aggregates of mutans streptococci. Acid production
by mutans streptococci. The metabolism of various saccharides (including glucose
and fructose) by the accumulated bacterial biofilm results in the production and
secretion of considerable amounts of the metabolic end - product lactic acid, which
can cause demineralization of the tooth structure when present in sufficient amounts
in close proximity to the tooth surface. This is thought to be the third event in the
formation of dental plaque, and it eventually results in a carious lesion.
Smoking and its relation to dental caries is may be due to high proportion of
sugar in some type of smokeless tobacco. Smoking increases thiocyanate level in
saliva. Thiocyanate, a normal constituent of saliva, was found to have a possible
caries inhibiting effect. Smoking is associated with lower salivary cystatin activity
and output of cystatin C during gingival inflammation. Cystatins are thought to
contribute to maintaining oral heath by inhibiting certain proteolytic enzymes. In
51
addition, studies have confirmed from earlier results that there were no significant
differences in salivary flow rates between smokers and non-smokers. The decreased
buffering effect of smoker’s saliva and the higher number of lactobacilli and S.
mutans group may indicate an increased susceptibility to caries.
Saliva is a complex oral fluid consisting of a mixture of secretions from the
major salivary glands and the minor glands of the oral mucosa. The normal
stimulated secretion rate in adults is 1 - 2 ml per minute. However, it may be reduced
to less than 0.1 ml per minute in individuals with severe salivary gland malfunction.
Salivary sampling protocols are advantageous in that they make for frequent and easy
collection of samples by non - invasive, stress - free techniques. Patients find little
difficulty in salivating into disposable tubes and can provide an adequate volume in
~10 min. Saliva represents the first line of defense against foreign pathogens as well
as commensal residents when high population densities can also be pathogenic.
Secretory IgA (S - IgA) is the prominent immunoglobulin in whole saliva and
is considered to be the main specific defense mechanism in the oral cavity. In
conjunction with several antimicrobial substances, including lysozyme, lactoferrin,
salivary peroxidase, and mucins, S - IgA may help maintain the oral cavity disease
free by limiting microbial adherence to epithelial and tooth surfaces by neutralizing
virulence factors. S-IgA may also prevent the penetration of antigens into the oral
mucosa. Passive smoking was associated with a decrease in secretory IgA
concentration in young children.
People with diabetes are at an increased risk of developing oral conditions like
periodontal disease, which has been associated with persistent poor glycemic control.
Periodontal disease can lead to recession of the gingival margin, which can expose
more tooth surfaces to caries attack. People with diabetes can also experience
hyposalivation and they may suffer from salivary dysfunction. Hyperglycemia in
children, adolescents, and adults with insulin-dependent diabetes mellitus have also
been associated with decreased salivary secretion and high salivary glucose. Aside
from calcium and phosphates that help remineralize tooth enamel, saliva also contains
components that can directly attack cariogenic bacteria. The absence of copious
52
saliva may result in minimizing buffer activity which promotes remineralization of
tooth structures early in the caries process. The reduction in saliva thus decreases
resistance to caries-producing bacteria. In addition, high glucose levels in the saliva
can increase the amount of fermentable carbohydrates by oral bacteria, leading to
production of acidic byproducts that cause teeth demineralization in dental caries.
Abundant glucose in the saliva may also promote the growth of cariogenic bacteria
and facilitate the frequency and duration of acidic episodes.
This man is also like to snacking which can cause diabetes mellitus,
malnutrition, and caries. Limiting lunch or dinner can avoid obesity and diabetes. Due
to not full, the stomach is filled with a piece or two pieces of biscuits and snacks like
potato chips. In fact, cookies, potato chips, and other sweet pastries containing high
carbohydrate content and without adequate food which called "snacking". All the
food was classified into foods with a high glycemic index. Meanwhile, sugar and
starch contained in it have a role in raising blood sugar levels.
Foods that contain saturated fat, trans fat or cholesterol are foods that can lead
to narrowing of the arteries due to plaque formation on artery walls. Foods that
contain saturated fat include meats with a high fat content and whole milk products
such as cheese and ice cream, store-bought cookies, cakes, doughnuts, mayonnaise
and palm oil. Foods with trans fat are cakes, cookies, crackers, pies, potato chips and
other processed foods which usually are from snack. Liver, pork, sausage and some
whole milk foods contain cholesterol. Other unhealthy foods are salty foods that can
raise blood pressure and sugar foods that can result diabetes when consumed in
excess.
Sugar as a sweetener virtually inseparable in everyday consumption. A variety
of food and drink was not good when not using sugar as a sweetener. The cookies are
also biscuits is synonymous with the sweetness of sugar, as well as enjoy tea, coffee
and other beverages will taste more delicious when added sugar. Sugar is included in
carbohydrates but not the main source of energy, is the main energy source of
complex carbohydrates. The use of too much sugar is not recommended. Whatever
type of sugar, if consumed in excess it can lead to various problems such as diabetes
53
and obesity. Health experts even say, sugar is toxic if consumed can be called more
than 8 teaspoons per day. And 8 teaspoons of sugar per day is equivalent to 291.2
calories.
Consuming excessive sugar, the pancreas has the ability to convert the sugar
limits to energy. If the pancreas is experiencing fatigue then one is the impact of
diabetes mellitus. Because of the sugar we consume will be converted into energy
used for various activities of cells and tissues, if the excessive amount of insulin will
take an important role. Insulin is a hormone produced by the pancreas Langerhans
cells will lower blood sugar. This mechanism made include increasing the rate of
glucose utilization through oxidation, glikogenesis (change glucose into glycogen)
and lipogenesis (change glucose into fat).
In patients with diabetes mellitus insulin production is inadequate result when
sugars and other carbohydrates as a result of the excessive glucose metabolism will
accumulate in the blood and an increase in blood sugar. which eventually can escape
from the process in the kidney so it would carry over into the urine. This can lead to
the emergence of symptoms of diabetes such as frequent urination and weight loss
because the body can not use the energy from food. If left untreated, diabetes can
cause blood sugar levels to be very high, which can lead to serious health conditions
or even death.
In both types of diabetes, the immune system plays a crucial role. Type 1
diabetes, or juvenile onset diabetes, is an autoimmune condition where the body’s
immune system overreacts and attacks the pancreas, effectively shutting off insulin
production, the important link to utilizing glucose within the body. There is also
increasing evidence that low-grade inflammation is involved in the progression of
Type 2 diabetes and associated complications. Elevated levels of some inflammatory
cytokines, such as tumor necrosis factor (TNF) - [ alpha ] and interleukin (IL) - 6,
may predict the development of Type 2 diabetes. Several drugs with anti -
inflammatory properties lower such markers, as well as blood sugar levels, while
possibly decreasing the risk of developing Type 2 diabetes. This mild state of
inflammation may be the common precedent of both Type 2 diabetes and
54
atherosclerosis (hardening of the arteries). Diabetics, both Type 1 and Type 2, are
often more susceptible to infections as a result of their bodies not being able to
properly utilize glucose. These diabetes - related complications include problems of
the heart, kidneys, eyes, feet and skin, nerves, teeth and gums.
Diabetes has a high glucosa level in the blood, which called hyperglycemia.
Hyperglycemia dangerous to the various cells and organ systems due to its effect on
the immune system, can act as a mediator of inflammation, resulting in vascular
response, and the response of brain cells. In a state of hyperglycemia easily occur due
to infection phagocyte dysfunction. Acute hyperglycemia can cause a variety of
adverse effects on the cardiovascular system, among others facilitate the occurrence
of heart failure. Incidence of thrombosis is often associated with hyperglycemia.
Hyperglycemia can lead to decreased plasma fibrinolytic activity and plasminogen
activator activity.
The most common problem that the patients suffering from diabetes face is
that as diabetes affects the immune system of the patients, the other organs of the
body start developing complications and abnormalities which hamper the regular
functioning of the organs effecting the body. Therefore it is relatively important for
diabetic patients to have mediation which will help in improving the immune system
of the body.
Snacking can also make an effect for dental. The one result effect of snacking
is dental caries. Dental caries occurs as a result of fluctuations in the pH of the dental
plaque in response to the availability of fermentable carbohydrates as a substrate for
the plaque bacteria. Frequent snacking on sugary foods, or even simply eating food
with low cariogenic potential, frequently will increase the development of the caries
lesion. Any fermentable carbohydrates can act as a food source for these bacteria.
Sucrose is the most potent of the extrinsic sugars, but lactose and fructose can also
produce significant reductions in plaque pH. The oral environment is in a constant
state of flux with changes in local pH occurring every time food is ingested.
All carbohydrate foods eventually break down into simple sugars: glucose,
fructose, maltose and lactose. Some foods, called fermentable carbohydrates, break
55
down in the mouth, whereas others don't break down until they move further down
the digestive tract. It's the fermentable carbohydrates that work with bacteria to begin
the decay process and eventually destroy teeth. They include the obvious sugary
foods, such as cookies, cakes, soft drinks and candy, but they also include less
obvious food, such as bread, crackers, bananas and breakfast cereals.
Certain bacteria on teeth use the sugars from these foods and produce acids.
These acids dissolve minerals inside the tooth enamel in a process called
demineralization. Teeth also regain minerals in a natural process called
remineralization. Saliva helps this process, as does fluoride and some foods. Dental
decay begins inside the tooth enamel when minerals are being lost faster than they are
being regained.
The longer food stays near the bacteria on the tooth, the more acids will be
produced. So sticky carbohydrates, such as raisins, can do more acid damage. But
other foods that pack into crevices can also cause decay. Potato chips are a terrific
example. Eat a handful of chips and see how long you have to work to get all the
stuck bits out from between your teeth. Teeth with a lot of nooks and crannies, such
as molars, are more likely to trap food and are more susceptible to decay. To make
matters worse, tooth-unhealthy foods don't create acids on teeth only while they are
being eaten. The acids stick around for the next half-hour. People who sip soft drinks
or sweetened coffee throughout the day or who eat many small sweet or carbohydrate
snacks provide a sugar source for the bacteria to produce acid almost constantly. And
because acid damage is cumulative, decay is more likely.
Poor oral hygiene in this diabetic man is a possible cause of an increase in
periodontal disease. A possible cause of increased plaque accumulation includes
increased glucose content of the saliva. This could provide nutrients for the
development of the plaque through production of extracellular polysaccharides such
as glucans and fructans. It has also been suggested that lack of compliance with
recommended diabetic therapy might in turn reflect on attitudes to maintenance of
oral health Oral hygiene varies according to socioeconomic status, age, sex and other
56
individual factors. Factors affecting oral hygiene must be reported in cross-sectional
studies in order to eliminate these as a confounding element in the analysis.
In periodontal disease, the materials that accumulates around the gingival
margin and contents of the pockets contain a large number of micro - organism, dead
and dying leucocytes and food debris. In addition, though protein content of food is
normally not altered during its usual brief sojourn in the mouth, it may be
decomposed by proteolytic bacteria if it is retained in these stagnation areas. Dental
caries is not usually considered to be responsible for alimentary disorders, yet if many
teeth are grossly affected, the bacterial flora of the mouth is considerably increased,
so that it is also a potential factor in spreading infection along the alimentary tract.
Dental plaque has been implicated as the prime etiologic factor in dental
caries, gingivitis, and periodontal disease. It is a complex bacterial biofilm
community for which the composition is governed by factors such as cell adherence,
coaggregation, and growth and survival in the environment. Plaque bacteria utilize
the readily fermentable carbohydrates on tooth surfaces to produce acids that promote
and prolong the cariogenic challenge to teeth, leading to enamel demineralization and
tooth decay. The development and progression of dental caries depends on the
amount of food particles that become trapped on the surfaces of teeth that may serve
as ready sources of fermentable carbohydrates, thereby promoting acid production by
plaque bacteria. This prolongs the cariogenic challenge to the teeth, leading to enamel
demineralization and tooth decay. To date, mechanical plaque elimination with
assorted devices remains the primary and most widely accepted means of maintaining
good oral hygiene and controling plaque-mediated diseases.
The development and progression of dental caries depends on both their
frequency of consumption of cariogenic carbohydrates and on the amount of food
particles that become trapped on the surfaces of teeth. Both of these serve as ready
sources of fermentable carbohydrates that promote acid production by plaque
bacteria. When plaque is not removed, the prolonged cariogenic challenge (pH below
the threshold of 5.5) leads to enamel demineralization and tooth decay. However, the
57
frequency of consumption of cariogenic carbohydrates plays a much larger role in
caries progression than the amount of food particles trapped on the surfaces of teeth.
Although bacteria are necessary for periodontal disease to take place, a
susceptible host is also needed. The immune-inflammatory response that develops in
the gingival and periodontal tissues in response to the chronic presence of plaque
bacteria results in destruction of structural components of the periodontium leading,
ultimately, to clinical signs of periodontitis The host response is essentially
protective, but both hyporesponsiveness and hyper-responsiveness of certain
pathways can result in enhanced tissue destruction. Both the host and bacteria in the
periodontal biofilm release proteolytic enzymes that damage tissue. They release
chemotactic factors that recruit poly morphonuclear leucocytes into the tissues; if
sustained, these cells release various enzymes that break down tissues. Hundreds or
even thousands of microbial antigens evoke both humoral antibody-mediated and
cell-mediated immune responses. These responses are usually protective, but a
sustained microbial challenge in the presence of the forementioned risk factors results
in the breakdown of both soft and hard tissues, mediated by cytokine and prostanoid
cascades.
Histologically, non-progressive inflammatory foci tend to be composed
predominantly of T lymphocytes and macrophages, suggesting that the cell-mediated
response can control disease. Destructive lesions are dominated by B lymphocytes
and plasma cells suggesting that humoral immunity is not always effective. Chronic
inflammation may result in central sensitization and wind-up pain. In cases of chronic
oral pain, neurons in the brain stem (nucleus caudalis) are chemically stimulated,
enhancing the frequency and intensity of the pain signal to the brain. Glutamate and
other chemicals bind to the NMDA receptor, sensitizing the postsynaptic neuron and
adding to the local pain response. Specific NMDA-receptor antagonists, such as
ketamine, can be used to counter this wind-up component of pain. Once a periodontal
pocket forms and becomes filled with bacteria, the situation becomes largely
irreversible. Gingival epithelium proliferates to line the pocket and even if treatment
resolves the inflammation and some bone and connective tissue are regenerated,
58
complete restoration of the lost tooth support is impossible. Without adequate
treatment, active periodontitis leads to tooth loss.
Related with the bad habits, snacking and smoking have a role in
memperparah periodontal disease. It can be complete with poor oral hygiene.
Smokers had more calculus than non-smokers, but the effect of smoking was
independent of the amount of calculus present. calculus formation is more abundant
in smokers may be due to the increased salivary flow rates. There is an increased
calcium concentration in fresh saliva in smokers following smoking. Nicotine affects
the exocrine glands by an initial increase in salivary and bronchial secretions that are
followed by inhibition of the secretions. The calcium phosphates found in
supragingival calculus are in the main derived from the saliva. The organic
components may also arise from this source, the proteins and polypeptides
constituting the major fraction. The increased amount of calculus found in smokers
might therefore be due to an effect of tobacco smoke upon properties of saliva.
Bleeding from the gum margin is an important early symptom of gingivitis,
and gingival bleeding on probing is now widely used in clinical examination as a
means of identifying active lesions in periodontal disease. Although smoking is
known to produce peripheral vasoconstriction, in some subjects this is preceded by
vasodilatation. In any particular instance, the effect produced is probably related to
the degree of inhalation of the tobacco smoke and the rate of nicotine absorption.
Nicotine from cigarette stimulates the sympathetic ganglia to produce
neurotransmitters including catecholamines. These affect the alpha-receptors on
blood vessels which in turn causes vasoconstriction. The vasoconstriction of
peripheral blood vessels caused by smoking can also effect the periodontal tissue as
smokers have less overt signs of gingivitis than nonsmokers and clinical signs of
gingival inflammation such as redness, bleeding and exudation are not as evident in
smokers. The vasoconstrictive actions of nicotine may be responsible for the
decreased gingival blood flow.
59
CHAPTER V
CLOSING
5.1 Conclusion
Infectious diseases are caused by a lot of microorganisms such as bacteria,
viruses, fungi, parasites. It could cause illness. Every particular individual creating an
immune response against the pathogen without eliciting any particular symptoms.
Caries is one of the ways the spread of infectious diseases namely acid bacteria that
could cause demineralisation and death pulpa and abscesses. This condition is getting
badly with the habit of smoking, smoking can trigger gingivitis, heavy smoker prone
to germs exposed to TB is aggravating the periodontal tissues. Diabetes mellitus as a
predisposition factor as well as create a network around the teeth or periodontal who
makes swollen.
5.2 Solution
Since we know that infectious disease and periodontal disease can cause by
any factors such as smoking, snacking etc. We have to decrease the number of those
bad habits or bad activity in our daily life so that the disease could not be more worse.
60
REFERENCES
1. Author. Periodontitis. Available at http://wikipedia.com/periodontitis.
Accesed December 2011
2. Larsen M, Bruun C. Caries chemistry and fluoride – mechanism of action
2nd.. Munksgaard:Copenhagen; 1994. .
3. Understanding Dental Health Francis G. Serio, DMD, MS Understanding
Health. Mississippi: University Press of Mississippi. 1998
4. Edwina A. M. Kidd. Essentials of dental caries: the disease and its
management. p 2-3
5. Author. Available at
http://www.ntvt.nl/userfiles/image/artikel/pdf/03dec510.PDF Accessed Nov 26 at
7:39
6. Author. Dentistry and Oral Medicine. Available at
http://www.medeco.de/en/dental-atlas/dentistry-and-oral-medicine/conservative
dental-medicine/. Accessed Nov 26 at 7:35
61
7. Hargreaves, KM. Goodis, HE. Seltzer and Bender’s Dental Pulp. Innate
immune responses of the dental pulp to caries. Journal of Endodontics. 2007. 33:643-
51.
8. Azodo CC. 2009. Current trends in the management of diabetes mellitus: the
Dentist’s perspective. Journal of Postgraduate Medicine. 11 (1) : p. 113
9. Alamo SM, Soriano YJ, Perez MGS. 2011. Dental considerations for the
patient with diabetes. J Clin Exp Dent. 3(1) : p. e.26
10. Wilson MH, Fitz Patric JJ, McArdle NS, Stassen LFA. 2010. Diabetes
Mellitus and Its Relevance to The Practice of Dentistry. Department of Oral &
Maxillofacial Surgery, Dublin Dental School & Hospital/St James’s Hospital. Journal
of the Irish Dental Association. 56 (3) : p. 128
11. Kidambi S, Patel SB. 2008. Diabetes Mellitus : Considerations for Dentistry.
The Journal of The America Dental Association . 139(suppl 5). pp 13S – 15S
12. Slootweg PJ. “Effect of tobacco smoking on periodontal tissue of 15 year old
school children,” Journal of Periodontal Research, vol. 8, no. 5, pp. 278–283, 2007
13. Cawson, “Effect of cigarette smoking on periodontal status of healthy young
adults,” Journal of Periodontology, vol. 71, no. 1, pp. 73–78, 2002
14. Calsina,“The association of periodontal disease parameters with systemic
medical conditions and tobacco use,” Journal of Clinical Periodontology, vol. 31, no.
8, pp. 625–632, 2002
15. Haber, “Occurrence of gingival bleeding in smoker and nonsmoker patients,”
Acta Odontologica Scandinavica, vol. 43, no. 5, pp. 315–320, 2000
16. Luzzi, “The effect of smoking on individuals with minimal periodontal
destruction,” Journal of Periodontology, vol. 69, no. 2, pp. 165–170, 2004
17. Feldman,“Association between cigarette smoking, bacterial pathogens, and
periodontal status,” Journal of Periodontology, vol. 64, no. 12, pp. 1225–1230, 2008
18. Nagaoka S, Miyazaki Y, Liu HJ, Iwamoto Y, Kitano M, Kawagoe M.
Bacterial invasion into dentinal tubules of human vital and nonvital teeth. J Endod
1995;21(2):70 –3
62
19. Knutsson G, Jontell M, Bergenholtz G. Determination of plasma proteins in
dentinal fluid from cavities prepared in healthy young human teeth. Arch Oral Biol
20. Speer ML, Madonia JV, Heuer MA. Quantitative evaluation of the
immunocompetence of the dental pulp. J Endod 1977;3(11):418 –23
21. Pulver WH, Taubman MA, Smith DJ. Immune components in normal and
inflamed human dental pulp. Arch Oral Biol 1977;22(2):103–11
22. Okamura K. Histological study on the origin of dentinal immunoglobulins and
the change in their localization during caries. J Oral Pathol 1985;14(9):680 –9
23. Hahn CL, Best AM. The pulpal origin of immunoglobulins in dentin beneath
caries: an immunohistochemical study. J Endod 2006;32:178–82
24. Challacombe SJ, Lehner T. Serum and salivary antibodies to cariogenic
bacteria in man. J Dent Res 1976;55 Spec No:C139–48.,
25. Challacombe SJ, Bergmeier LA, Czerkinsky C, Rees AS. Natural antibodies
in man to Streptococcus mutans: specificity and quantification. Immunology
1984;52(1):143–50
26. Frank MM, Joiner K, Hammer C. The function of antibody and complement
in the lysis of bacteria. Rev Infect Dis 1987;9 Suppl 5:S537– 45.
27. Taylor PW. Complement-mediated killing of susceptible gram-negative
bacteria: an elusive mechanism. Exp Clin Immunogenet 1992;9(1):48 –56.
28. Pekovic DD, Adamkiewicz VW, Shapiro A, Gornitsky M. Identification of
bacteria in association with immune components in human carious dentin. J Oral
Pathol 1987;16(5):223–33
29. Izumi T, Kobayashi I, Okamura K, Sakai H. Immunohistochemical study on
the immunocompetent cells of the pulp in human non-carious and carious teeth.
Archs Oral Biol 1995;40:609 –14.
30. Baume LJ. Dental pulp conditions in relation to carious lesions. Int Dent J
1970;20(2):309 –37.
31. Brannstrom M, Lind PO. Pulpal response to early dental caries. J Dent Res
1965;44:1045–50.
63
32. Abbas A, Lichtman A. Cellular and molecular immunology, 5th ed.
Philadelphia: Saunders, 2003
33. Ackermans F, Klein JP, Frank RM. Ultrastructural localization of
immunoglobulins in carious human dentine. Arch Oral Biol 1981;26(11):879–86.
34. Okamura K, Maeda M, Nishikawa T, Tsutsui M. Dentinal response against
carious invasion: localization of antibodies in odontoblastic body and process. J Dent
Res 1980;59(8):1368 –73.
35. Hahn CL, Overton B. The effects of immunoglobulins on the convective
permeability of human dentine in vitro. Arch Oral Biol 1997;42(12):835– 43.
36. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev
Immunol 2005;5(12):953– 64.
37. Trinchieri G. Interleukin-12: a proinflammatory cytokine with
immunoregulatory functions that bridge innate resistance and antigen-specific
adaptive immunity.Annu Rev Immunol 1995;13:251–76.
38. Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zum Buschenfelde
KH, Neurath MF. IL-12 and IL-18 differentially regulate the transcriptional activity
of the human IFN-gamma promoter in primary CD4_ T lymphocytes. J Immunol
1998;160(8):3642–7.
39. Abbas A, Lichtman A. Cellular and molecular immunology, 5th ed.
Philadelphia: Saunders, 2003
40. Hahn CL, Best AM, Tew JG. Cytokine induction by Streptococcus mutans
and pulpal pathogenesis. Infect Immun 2000;68(12):6785–9.
41. Zehnder M, Delaleu N, Du Y, Bickel M. Cytokine gene expression—part of
host defence in pulpitis. Cytokine 2003;22(3– 4):84–8.
42. Rodd HD, Boissonade FM. Immunocytochemical investigation of
neurovascular relationships in human tooth pulp. J Anat 2003;202(2):195–203.
43. Awawdeh L, Lundy FT, Shaw C, Lamey PJ, Linden GJ, Kennedy JG.
Quantitative analysis of substance P, neurokinin A and calcitonin gene-related
peptide in pulp tissue from painful and healthy human teeth. Int Endod J
2002;35(1):30–6.
64
44. Bowles WR, Withrow JC, Lepinski AM, Hargreaves KM. Tissue levels of
immunoreactive substance P are increased in patients with irreversible pulpitis. J
Endod 2003;29(4):265–7.
45. Rodd HD, Boissonade FM. Substance P expression in human tooth pulp in
relation to caries and pain experience. Eur J Oral Sci 2000;108(6):467–74.
46. Olgart L, Kerezoudis NP. Nerve-pulp interactions. Arch Oral Biol 1994;39
Suppl:47S–54S.
47. Huang GT, Potente AP, Kim JW, Chugal N, Zhang X. Increased interleukin-8
expression in inflamed human dental pulps. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod 1999;88(2):214 –20.
48. Hahn CL, Falkler WA Jr, Siegel MA. A study of T and B cells in pulpal
pathosis. J Endod 1989;15(1):20–6.
49. Pietschmann P, Cush JJ, Lipsky PE, Oppenheimer-Marks N. Identification of
subsets of human T cells capable of enhanced transendothelial migration. J Immunol
1992;149(4):1170–8.
50. Rohnelt RK, Hoch G, Reiss Y, Engelhardt B. Immunosurveillance modelled
in vitro: naive and memory T cells spontaneously migrate across unstimulated
microvascular endothelium. Int Immunol 1997;9(3):435–50
51. Marshall DR, Turner SJ, Belz GT, Wingo S, Andreansky S, Sangster MY, et
al. Measuring the diaspora for virus-specific CD8_ T cells. Proc Natl Acad Sci USA
2001;98(11):6313– 8.
52. Masopust D, Vezys V, Usherwood EJ, Cauley LS, Olson S, Marzo AL, et al.
Activated primary and memory CD8 T cells migrate to nonlymphoid tissues
regardless of site of activation or tissue of origin. J Immunol 2004;172(8):4875– 82.
53. Klonowski KD, Lefrancois L. The CD8 memory T cell subsystem: integration
of homeostatic signaling during migration. Semin Immunol 2005;17(3):219 –29.
54. Chong BF, Murphy JE, Kupper TS, Fuhlbrigge RC. E-selectin, thymus- and
activationregulated chemokine/CCL17, and intercellular adhesion molecule-1 are
constitutively coexpressed in dermal microvessels: a foundation for a cutaneous
immunosurveillance system. J Immunol 2004;172(3):1575– 81.
65
55. Sawa Y, Yoshida S, Shibata KI, Suzuki M, Mukaida A. Vascular endothelium
of human dental pulp expresses diverse adhesion molecules for leukocyte emigration.
Tissue Cell 1998;30(2):281–91
56. Raja Alamelu. 2004. Immunology Of Tuberculosis. Indian J Med Res. pp 213-
232
57. Anonim. 2007. Tuberculosis (TB). New York State Department Of Health. pp
1-2
58. American Academy of Pediatrics. 2003. Tuberculosis. In: Pickering LK, ed.
Red Book. pp 642-660.
59. Zang Y. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J
Tuberc Lung Dis. 2009; 13 (11): pp 1320-1330
66